The 2003-2008 World Outlook for Biotechnology 0597866147, 9780597866142


319 8 926KB

English Pages 227

Report DMCA / Copyright

DOWNLOAD PDF FILE

Recommend Papers

The 2003-2008 World Outlook for Biotechnology
 0597866147, 9780597866142

  • 0 0 0
  • Like this paper and download? You can publish your own PDF file online for free in a few minutes! Sign Up
File loading please wait...
Citation preview

The 2003-2008 World Outlook for Biotechnology

by Philip M. Parker, Ph.d. Eli Lilly Chaired Professor of Business, Innovation and Society INSEAD (Singapore, and Fontainebleau, France)

www.icongrouponline.com

Ó2003 ICON Group Ltd.

ii

COPYRIGHT NOTICE ISBN: 0-597-86614-7

All of ICON Group Ltd. publications are copyrighted. Copying our publications in whole or in part, for whatever reason, is a violation of copyright laws and can lead to penalties and fines. Should you want to copy tables, graphs or other materials from our publications, please contact us to request permission. ICON Group Ltd. often grants permission for very limited reproduction of our publications for internal use, press releases, and academic research. Such reproduction requires, however, confirmed permission from ICON Group Ltd. Please read the full copyright notice, disclaimer, and user agreement provisions at the end of this report.

IMPORTANT DISCLAIMER

Neither ICON Group Ltd. nor its employees or the author of this report can be held accountable for the use and subsequent actions of the user of the information provided in this publication. Great efforts have been made to ensure the accuracy of the data, but we can not guarantee, given the volume of information, accuracy. Since the information given in this report is forward-looking, the reader should read the disclaimer statement and user agreement provisions at the end of this report.

www.icongrouponline.com

Ó2003 ICON Group Ltd.

iii

About the Author Dr. Philip M. Parker is the Eli Lilly Chaired Professor of Innovation, Business and Society at INSEAD where he has taught courses on global competitive strategy since 1988. He has also taught courses at MIT, Stanford University, Harvard University, UCLA, UCSD, and the Hong Kong University of Science and Technology. Professor Parker is the author of six books on the economic convergence of nations. These books introduce the notion of “physioeconomics” which foresees a lack of global convergence in economic behaviors due to physiological and physiographic forces. His latest book is "Physioeconomics: the basis for long-run economic growth" (MIT Press 2000). He has also published numerous articles in academic journals, including, the Rand Journal of Economics, Marketing Science, the Journal of International Business Studies, Technological Forecasting and Social Change, the International Journal of Forecasting, the European Management Journal, the European Journal of Operational Research, the Journal of Marketing, the International Journal of Research in Marketing, and the Journal of Marketing Research. He is also on the editorial boards of several academic journals. Dr. Parker received his Ph.D. in Business Economics from the Wharton School of the University of Pennsylvania and has Masters degrees in Finance and Banking (University of Aix-Marseille) and Managerial Economics (Wharton). His undergraduate degrees are in mathematics, biology and economics (minor in aeronautical engineering). He has consulted and/or taught courses in Africa, the Middle East, Asia, Latin America, North America and Europe.

About this Series This series was created for international firms who rely on foreign markets for a substantial portion of their business or who might be threatened by international competition. The estimates given in this report were created using a methodology developed by and implemented under the direct supervision of Professor Philip M. Parker, the Eli Lilly Chaired Professor of Innovation, Business and Society, at INSEAD. The methodology relies on historical figures across countries. Reported figures should be seen as estimates of past and future levels of latent demand.

Acknowledgements Some of the methodologies and research approaches used in this report have benefited from the R&D Committee at INSEAD, whose research support is gratefully acknowledged.

www.icongrouponline.com

Ó2003 ICON Group Ltd.

iv

About ICON Group Ltd. ICON Group Ltd.’s primary mission is to assist managers with their international information needs. U.S.-owned and operated, ICON Group has field offices in Paris, Hong Kong and Lomé, Togo (West Africa). Created in 1994, ICON Group has published hundreds of multi-client databases, and global/regional market data, industry and country publications. Global/Regional Management Studies. Summarizing over 190 countries, management studies are generally organized into regional volumes and cover key management functions. The human resource series covers minimum wages, child labor, unionization and collective bargaining. The international law series covers media control and censorship, search and seizure, and trial justice and punishment. The diversity management series covers a variety of environmental context drivers that effect global operations. These include women’s rights, children’s rights, discrimination/racism, and religious forces and risks. Global strategic planning studies cover economic risk assessments, political risk assessments, foreign direct investment strategy, intellectual property strategy, and export strategies. Financial management studies cover taxes and tariffs. Global marketing studies focus on target segments (e.g. seniors, children, women) and strategic marketing planning. Country Studies: Often managers need an in-depth, yet broad and up-to-date understanding of a country’s strategic market potential and situation before the first field trip or investment proposal. There are over 190 country studies available. Each study consists of analysis, statistics, forecasts, and information of relevance to managers. The studies are continually updated to insure that the reports have the most relevant information available. In addition to raw information, the reports provide relevant analyses which put a more general perspective on a country (seen in the context of relative performance vis-à-vis benchmarks). Industry Studies: Companies are racing to become more international, if not global in their strategies. For over 2000 product/industry categories, these reports give the reader a concise summary of latent market forecasts, pro-forma financials, import competition profiles, contacts, key references and trends across 200 countries of the world. Some reports focus on a particular product and region (up to four regions per product), while others focus on a product within a particular country.

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Contents

v

Table of Contents 1

INTRODUCTION

1.1 1.2 1.3 1.3.1 1.3.2 1.3.3 1.3.4 1.3.5 1.3.6 1.3.7

2

Step 1. Product Definition and Data Collection Step 2. Filtering and Smoothing Step 3. Filling in Missing Values Step 4. Varying Parameter, Non-linear Estimation Step 5. Fixed-Parameter Linear Estimation Step 6. Aggregation and Benchmarking Step 7. Latent Demand Density: Allocating Across Cities

SUMMARY OF FINDINGS

2.1 3

Overview What is Latent Demand and the P.I.E.? The Methodology

The Worldwide Market Potential for Biotechnology

AFRICA: BIOTECHNOLOGY

3.1 3.2 3.3 3.4 3.5 3.6 3.7 3.8 3.9 3.10 3.11 3.12 3.13 3.14 3.15 3.16 3.17 3.18 3.19 3.20 3.21 3.22 3.23 3.24 3.25 3.26 3.27 3.28 3.29

Executive Summary Algeria Angola Benin Botswana Burkina Faso Burundi Cameroon Cape Verde Central African Republic Chad Comoros Congo (formerly Zaire) Ivory coast Djibouti Egypt Equatorial Guinea Ethiopia Gabon Ghana Guinea Guinea-Bissau Kenya Lesotho Liberia Libya Madagascar Malawi Mali

www.icongrouponline.com

11

11 11 12 14 16 16 16 17 17 17

19

19 21

21 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 Ó2003 ICON Group Ltd.

Contents

3.30 3.31 3.32 3.33 3.34 3.35 3.36 3.37 3.38 3.39 3.40 3.41 3.42 3.43 3.44 3.45 3.46 3.47 3.48 3.49 3.50 3.51 3.52 3.53 3.54 4

Mauritania Mauritius Morocco Mozambique Namibia Niger Nigeria Republic of Congo Reunion Rwanda Sao Tome E Principe Senegal Sierra Leone Somalia South Africa Sudan Swaziland Tanzania The Gambia Togo Tunisia Uganda Western Sahara Zambia Zimbabwe

ASIA: BIOTECHNOLOGY

4.1 4.2 4.3 4.4 4.5 4.6 4.7 4.8 4.9 4.10 4.11 4.12 4.13 4.14 4.15 4.16 4.17 4.18

Executive Summary Bangladesh Bhutan Brunei Burma Cambodia China Hong Kong India Indonesia Japan Laos Macau Malaysia Maldives Mongolia Nepal North Korea

www.icongrouponline.com

vi

51 52 53 54 55 56 57 58 59 60 61 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75

75 77 78 79 80 81 81 82 83 84 85 86 87 88 89 89 90 91 Ó2003 ICON Group Ltd.

Contents

4.19 4.20 4.21 4.22 4.23 4.24 4.25 4.26 4.27 5

vii

Papua New Guinea Philippines Seychelles Singapore South Korea Sri Lanka Taiwan Thailand Vietnam

92 93 94 95 95 96 97 98 99

EUROPE: BIOTECHNOLOGY

101

5.1 5.2 5.3 5.4 5.5 5.6 5.7 5.8 5.9 5.10 5.11 5.12 5.13 5.14 5.15 5.16 5.17 5.18 5.19 5.20 5.21 5.22 5.23 5.24 5.25 5.26 5.27 5.28 5.29 5.30 5.31 5.32 5.33 5.34

Executive Summary Albania Andorra Austria Belarus Belgium Bosnia and Herzegovina Bulgaria Croatia Cyprus Denmark Estonia Finland France Georgia Germany Greece Hungary Iceland Ireland Italy Kazakhstan Latvia Liechtenstein Lithuania Luxembourg Malta Moldova Monaco Netherlands Norway Poland Portugal Romania

www.icongrouponline.com

101 103 104 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 129 130 131 132 133 Ó2003 ICON Group Ltd.

Contents

5.35 5.36 5.37 5.38 5.39 5.40 5.41 5.42 5.43 6

LATIN AMERICA: BIOTECHNOLOGY

6.1 6.2 6.3 6.4 6.5 6.6 6.7 6.8 6.9 6.10 6.11 6.12 6.13 6.14 6.15 6.16 6.17 6.18 6.19 6.20 6.21 6.22 6.23 7

Russia San Marino Slovakia Slovenia Spain Sweden Switzerland Ukraine United Kingdom Executive Summary Argentina Belize Bolivia Brazil Chile Colombia Costa Rica Ecuador El Salvador Falkland Islands French Guiana Guatemala Guyana Honduras Mexico Nicaragua Panama Paraguay Peru Suriname Uruguay Venezuela

NORTH AMERICA & THE CARIBBEAN: BIOTECHNOLOGY

7.1 7.2 7.3 7.4 7.5 7.6 7.7 7.8 7.9

Executive Summary Antigua and Barbuda Aruba Bahamas Barbados Bermuda Canada Cayman Islands Cuba

www.icongrouponline.com

viii

134 135 136 137 138 139 140 141 142 143

143 145 146 147 148 149 150 151 152 153 154 154 155 156 157 158 159 160 161 162 163 164 165 166

166 168 168 169 170 170 171 172 173 Ó2003 ICON Group Ltd.

Contents

7.10 7.11 7.12 7.13 7.14 7.15 7.16 7.17 7.18 7.19 7.20 7.21 7.22 7.23 7.24 7.25 8

OCEANA: BIOTECHNOLOGY

8.1 8.2 8.3 8.4 8.5 8.6 8.7 8.8 8.9 8.10 8.11 8.12 8.13 8.14 8.15 8.16 9

Dominica Dominican Republic Greenland Grenada Guadeloupe Haiti Jamaica Martinique Netherlands Antilles Puerto Rico St. Kitts and Nevis St. Lucia St. Vincent and the Grenadines Trinidad and Tobago United States Virgin Islands, US Executive Summary American Samoa Australia Fiji French Polynesia Guam Kiribati Nauru New Caledonia New Zealand Northern Mariana Island Solomon Islands Tonga Tuvalu Vanuatu Western Samoa

THE MIDDLE EAST: BIOTECHNOLOGY

9.1 9.2 9.3 9.4 9.5 9.6 9.7 9.8 9.9

Executive Summary Afghanistan Armenia Azerbaijan Bahrain Iran Iraq Israel Jordan

www.icongrouponline.com

ix

174 175 176 177 177 178 179 180 181 182 183 183 184 185 186 187 188

188 190 191 192 192 193 194 194 195 196 197 197 198 199 199 200 201

201 203 204 205 206 207 208 209 210 Ó2003 ICON Group Ltd.

Contents

9.10 9.11 9.12 9.13 9.14 9.15 9.16 9.17 9.18 9.19 9.20 9.21 9.22 9.23 10

Kuwait Kyrgyzstan Lebanon Oman Pakistan Qatar Saudi Arabia Syrian Arab Republic Tajikistan Turkey Turkmenistan United Arab Emirates Uzbekistan Yemen

211 212 213 214 215 216 216 217 218 219 220 221 222 223

DISCLAIMERS, WARRANTEES, AND USER AGREEMENT PROVISIONS

10.1 10.2

Disclaimers & Safe Harbor ICON Group Ltd. User Agreement Provisions

www.icongrouponline.com

x

224

224 225

Ó2003 ICON Group Ltd.

Biotechnology

11

1 INTRODUCTION 1.1 OVERVIEW This study covers the world outlook for biotechnology across more than 200 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. This study does not report actual sales data (which are simply unavailable, in a comparable or consistent manner in virtually all of the 230 countries of the world). This study gives, however, my estimates for the worldwide latent demand, or the P.I.E. for biotechnology. It also shows how the P.I.E. is divided across the world’s regional and national markets. For each country, I also show my estimates of how the P.I.E. grows over time (positive or negative growth). In order to make these estimates, a multi-stage methodology was employed that is often taught in courses on international strategic planning at graduate schools of business.

1.2 WHAT IS LATENT DEMAND AND THE P.I.E.? The concept of latent demand is rather subtle. The term latent typically refers to something that is dormant, not observable or not yet realized. Demand is the notion of an economic quantity that a target population or market requires under different assumptions of price, quality, and distribution, among other factors. Latent demand, therefore, is commonly defined by economists as the industry earnings of a market when that market becomes accessible and attractive to serve by competing firms. It is a measure, therefore, of potential industry earnings (P.I.E.) or total revenues (not profit) if a market is served in an efficient manner. It is typically expressed as the total revenues potentially extracted by firms. The “market” is defined at a given level in the value chain. There can be latent demand at the retail level, at the wholesale level, the manufacturing level, and the raw materials level (the P.I.E. of higher levels of the value chain being always smaller than the P.I.E. of levels at lower levels of the same value chain, assuming all levels maintain minimum profitability). The latent demand for biotechnology is not actual or historic sales. Nor is latent demand future sales. In fact, latent demand can be lower either lower or higher than actual sales if a market is inefficient (i.e. not representative of relatively competitive levels). Inefficiencies arise from a www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

12

number of factors, including the lack of international openness, cultural barriers to consumption, regulations, and cartel-like behavior on the part of firms. In general, however, latent demand is typically larger than actual sales in a country market. For reasons discussed later, this report does not consider the notion of “unit quantities”, only total latent revenues (i.e. a calculation of price times quantity is never made, though one is implied). The units used in this report are U.S. dollars not adjusted for inflation (i.e. the figures incorporate inflationary trends) and not adjusted for future dynamics in exchange rates (i.e. the figures reflect average exchange rates over recent history). If inflation rates or exchange rates vary in a substantial way compared to recent experience, actually sales can also exceed latent demand (when expressed in U.S. dollars, not adjusted for inflation). On the other hand, latent demand can be typically higher than actual sales as there are often distribution inefficiencies that reduce actual sales below the level of latent demand. As mentioned in the introduction, this study is strategic in nature, taking an aggregate and longrun view, irrespective of the players or products involved. If fact, all the current products or services on the market can cease to exist in their present form (i.e. at a brand-, R&D specification, or corporate-image level) and all the players can be replaced by other firms (i.e. via exits, entries, mergers, bankruptcies, etc.), and there will still be an international latent demand for biotechnology at the aggregate level. Product and service offering details, and the actual identity of the players involved, while important for certain issues, are relatively unimportant for estimates of latent demand.

1.3 THE METHODOLOGY In order to estimate the latent demand for biotechnology on a worldwide basis, I used a multistage approach. Before applying the approach, one needs a basic theory from which such estimates are created. In this case, I heavily rely on the use of certain basic economic assumptions. In particular, there is an assumption governing the shape and type of aggregate latent demand functions. Latent demand functions relate the income of a country, city, state, household, or individual to realized consumption. Latent demand (often realized as consumption when an industry is efficient), at any level of the value chain, takes place if an equilibrium in realized. For firms to serve a market, they must perceive a latent demand and be able to serve that demand at a minimal return. The single most important variable determining consumption, assuming latent demand exists, is income (or other financial resources at higher levels of the value chain). Other factors that can pivot or shape demand curves include external or exogenous shocks (i.e. business cycles), and or changes in utility for the product in question. Ignoring, for the moment, exogenous shocks and variations in utility across countries, the aggregate relation between income and consumption has been a central theme in economics. The figure below concisely summarizes one aspect of problem. In the 1930s, John Meynard Keynes conjectured that as incomes rise, the average propensity to consume would fall. The average

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

13

propensity to consume is the level of consumption divided by the level of income, or the slope of the line from the origin to the consumption function. He estimated this relationship empirically and found it to be true in the short-run (mostly based on cross-sectional data). The higher the income, the lower the average propensity to consume. This type of consumption function is labeled "A" in the figure below (note the rather flat slope of the curve). In the 1940s, another macroeconomist, Simon Kuznets, estimated long-run consumption functions which indicated that the marginal propensity to consume was rather constant (using time series data across countries). This type of consumption function is show as "B" in the figure below (note the higher slope and zero-zero intercept).1 The average propensity to consume is constant.

Latent Demand

B

A

Income Is it declining or is it constant? A number of other economists, notably Franco Modigliani and Milton Friedman, in the 1950s (and Irving Fisher earlier), explained why the two functions were different using various assumptions on intertemporal budget constraints, savings, and wealth. The shorter the time horizon, the more consumption can depend on wealth (earned in previous years) and business cycles. In the long-run, however, the propensity to consume is more constant. Similarly, in the long run, households, industries or countries with no income eventually have no consumption (wealth is depleted). While the debate surrounding beliefs about how income and consumption are related and interesting, in this study a very particular school of thought is adopted. In particular, we are considering the latent demand for biotechnology across some 230 countries. The smallest have fewer than 10,000 inhabitants. I assume that all of these counties fall along a "long-run" aggregate consumption function. This long-run function applies despite some 1

For a general overview of this subject area, see Principles of Macroeconomics by N. Gregory Mankiw, SouthWestern College Publishing; ISBN: 0030340594; 2nd edition (February 2002). www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

14

of these countries having wealth, current income dominates the latent demand for biotechnology. So, latent demand in the long-run has a zero intercept. However, I allow firms to have different propensities to consume (including being on consumption functions with differing slopes, which can account for differences in industrial organization, and end-user preferences). Given this overriding philosophy, I will now describe the methodology used to create the latent demand estimates for biotechnology. Since ICON Group has asked me to apply this methodology to a large number of categories, the rather academic discussion below is general and can be applied to a wide variety of categories, not just biotechnology.

1.3.1

Step 1. Product Definition and Data Collection

Any study of latent demand across countries requires that some standard be established to define “efficiently served”. Having implemented various alternatives and matched these with market outcomes, I have found that the optimal approach is to assume that certain key countries are more likely to be at or near efficiency than others. These countries are given greater weight than others in the estimation of latent demand compared to other countries for which no known data are available. Of the many alternatives, I have found the assumption that the world’s highest aggregate income and highest income-per-capita markets reflect the best standards for “efficiency”. High aggregate income alone is not sufficient (i.e. China has high aggregate income, but low income per capita and can not assumed to be efficient). Aggregate income can be operationalized in a number of ways, including gross domestic product (for industrial categories), or total disposable income (for household categories; population times average income per capita, or number of households times average household income per capita). Brunei, Nauru, Kuwait, and Lichtenstein are examples of countries with high income per capita, but not assumed to be efficient, given low aggregate level of income (or gross domestic product); these countries have, however, high incomes per capita but may not benefit from the efficiencies derived from economies of scale associated with large economies. Only countries with high income per capita and large aggregate income are assumed efficient. This greatly restricts the pool of countries to those in the OECD (Organization for Economic Cooperation and Development), like the United States, or the United Kingdom (which were earlier than other large OECD economies to liberalize their markets). The selection of countries is further reduced by the fact that not all countries in the OECD report industry revenues at the category level. Countries that typically have ample data at the aggregate level that meet the efficiency criteria include the United States, the United Kingdom and in some cases France and Germany. Latent demand is therefore estimated using data collected for relatively efficient markets from independent data sources (e.g. Euromonitor, Mintel, Thomson Financial Services, the U.S. Industrial Outlook, the World Resources Institute, the Organization for Economic Cooperation and Development, various agencies from the United Nations, industry trade associations, the International Monetary Fund, and the World Bank). Depending on original data sources used, the www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

15

definition of “biotechnology” is established. In the case of this report, the data were reported at the aggregate level, with no further breakdown or definition. In other words, any potential product or service that might be incorporated within biotechnology falls under this category. Public sources rarely report data at the disaggregated level in order to protect private information from individual firms that might dominate a specific product-market. These sources will therefore aggregate across components of a category and report only the aggregate to the public. While private data are certainly available, this report only relies on public data at the aggregate level without reliance on the summation of various category components. In other words, this report does not aggregate a number of components to arrive at the “whole”. Rather, it starts with the “whole”, and estimates the whole for all countries and the world at large (without needing to know the specific parts that went into the whole in the first place). Given this caveat, this study covers “biotechnology” as defined by the Standard Industrial Classification code system used in various U.S. government sources. In spite of the more recent system North American Industrial Classification system or NAICs (pronounced “nakes”), the SIC system is still in use in various publications that estimate industrial output. For a complete definition of biotechnology, please refer to the Web site at: http://155.103.6.10/cgibin/sic/sicser2?8731, maintained by the U.S. government. The SIC for biotechnology is 8731. It is for this definition of biotechnology that the aggregate latent demand estimates are derived.

SIC Description for 8731 8731: Commercial Physical and Biological Research Establishments primarily engaged in commercial physical and biological research and development on a contract or fee basis. Noncommercial research establishments funded by endowments, grants, or contributions are classified in Industry 8733. Separate establishments of aircraft, guided missile, or spacecraft manufacturers primarily engaged in research and development on these products are classified in Manufacturing, Major Group 37. · Agricultural research, · Biological research commercial · Chemical laboratories, commercial research except testing · Engineering laboratories, commercial research: except testing · Food research commercial · Industrial laboratories commercial research: except testing · Physical research commercial · Research and development physical and biological: commercial

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

1.3.2

16

Step 2. Filtering and Smoothing

Based on the aggregate view of biotechnology as defined above, data were then collected for as many similar countries as possible for that same definition, at the same level of the value chain. This generates a convenience sample of countries from which comparable figures are available. If the series in question do not reflect the same accounting period, then adjustments are made. In order to eliminate short-term effects of business cycles, the series are smoothed using an 2 year moving average weighting scheme (longer weighting schemes do not substantially change the results). If data are available for a country, but these reflect short-run aberrations due to exogenous shocks (such as would be the case of beef sales in a country stricken with foot and mouth disease), these observations were dropped or "filtered" from the analysis.

1.3.3

Step 3. Filling in Missing Values

In some cases, data are available for countries on a sporadic basis. In other cases, data from a country may be available for only one year. From a Bayesian perspective, these observations should be given greatest weight in estimating missing years. Assuming that other factors are held constant, the missing years are extrapolated using changes and growth in aggregate national income. Based on the overriding philosophy of a long-run consumption function (defined earlier), countries which have missing data for any given year, are estimated based on historical dynamics of aggregate income for that country.2

1.3.4

Step 4. Varying Parameter, Non-linear Estimation

Given the data available from the first three steps, the latent demand in additional countries is estimated using a “varying-parameter cross-sectionally pooled time series model”.3 Simply stated, the effect of income on latent demand is assumed to be constant across countries unless there is empirical evidence to suggest that this effect varies (i.e. . the slope of the income effect is not necessarily same for all countries). This assumption applies across countries along the aggregate consumption function, but also over time (i.e. not all countries are perceived to have the same income growth prospects over time and this effect can vary from country to country as 2

This report was prepared from a variety of sources including excerpts from documents and official reports or databases published by the World Bank, the U.S. Department of Commerce, the U.S. State Department, various national agencies, the International Monetary Fund, the Central Intelligence Agency, various agencies from the United Nations (e.g. ILO, ITU, UNDP, etc.), and non-governmental sources, including ICON Group Ltd., Euromonitor, the World Resources Institute, Mintel, the U.S. Industrial Outlook, and various public sources cited in the trade press. 3 The interested reader can find longer discussions of this type of modeling in Studies in Global Econometrics (Advanced Studies in Theoretical and Applied Econometrics V. 30), by Henri Theil, et al., Kluwer Academic Publishers; ISBN: 0792336607; (June 1996), and in Principles of Econometrics, by Henri Theil John Wiley & Sons; ISBN: 0471858455; (December 1971), and in Econometric Models and Economic Forecasts by Robert S. Pindyck, Daniel L. Rubinfeld McGraw Hill Text; ISBN: 0070500983; 3rd edition (December 1991). www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

17

well). Another way of looking at this is to say that latent demand for biotechnology is more likely to be similar across countries that have similar characteristics in terms of economic development (i.e. African countries will have similar latent demand structures controlling for the income variation across the pool of African countries). This approach is useful across countries for which some notion of non-linearity exists in the aggregate cross-country consumption function. For some categories, however, the reader must realize that the numbers will reflect a country’s contribution to global latent demand and may never be realized in the form of local sales. For certain country-category combinations this will result in what at first glance will be odd results. For example, the latent demand for the category “space vehicles” will exist for “Togo” even though they have no space program. The assumption is that if the economies in these countries did not exist, the world aggregate for these categories would be lower. The share attributed to these countries is based on a proportion of their income (however small) being used to consume the category in question (i.e. perhaps via resellers).

1.3.5

Step 5. Fixed-Parameter Linear Estimation

Nonlinearities are assumed in cases where filtered data exist along the aggregate consumption function. Because the world consists of more than 200 countries, there will always be those countries, especially toward the bottom of the consumption function, where non-linear estimation is simply not possible. For these countries, equilibrium latent demand is assumed to be perfectly parametric and not a function of wealth (i.e. a country’s stock of income), but a function of current income (a country’s flow of income). In the long run, if a country has no current income, the latent demand for biotechnology is assumed to approach zero. The assumption is that wealth stocks fall rapidly to zero if flow income falls to zero (i.e. countries which earn low levels of income will not use their savings, in the long run, to demand biotechnology). In a graphical sense, for low income countries, latent demand approaches zero in a parametric linear fashion with a zero-zero intercept. In this stage of the estimation procedure, low-income countries are assumed to have a latent demand proportional to their income, based on the country closest to it on the aggregate consumption function.

1.3.6

Step 6. Aggregation and Benchmarking

Based on the models described above, latent demand figures are estimated for all countries of the world, including for the smallest economies. These are then aggregated to get world totals and regional totals. To make the numbers more meaningful, regional and global demand averages are presented. Figures are rounded, so minor inconsistencies may exist across tables.

1.3.7

Step 7. Latent Demand Density: Allocating Across Cities

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

18

With the advent of a “borderless world”, cities become a more important criteria in prioritizing markets, as opposed to regions, continents, or countries. This report also covers the world’s top 2000 cities. The purpose is to understand the density of demand within a country and the extent to which a city might be used as a point of distribution within its region. From an economic perspective, however, a city does not represent a population within rigid geographical boundaries. To an economist or strategic planner, a city represents an area of dominant influence over markets in adjacent areas. This influence varies from one industry to another, but also from one period of time to another. Similar to country-level data, the reader needs to realize that latent demand allocated to a city may or may not represent real sales. For many items, latent demand is clearly observable in sales, as in the case for food or housing items. Consider, again, the category “satellite launch vehicles.” Clearly, there are no launch pads in most cities of the world. However, the core benefit of the vehicles (e.g. telecommunications, etc.) is "consumed" by residents or industries within the world's cities. Without certain cities, in other words, the world market for satellite launch vehicles would be lower for the world in general. One needs to allocate, therefore, a portion of the worldwide economic demand for launch vehicles to regions, countries and cities. This report takes the broader definition and considers, therefore, a city as a part of the global market. I allocate latent demand across areas of dominant influence based on the relative economic importance of cities within its home country, within its region and across the world total. Not all cities are estimated within each country as demand may be allocated to adjacent areas of influence. Since some cities have higher economic wealth than others within the same country, a city’s population is not generally used to allocate latent demand. Rather, the level of economic activity of the city vis-à-vis others.

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

19

2 SUMMARY OF FINDINGS Based on the methodology described above, the latent demand for biotechnology is estimated to be $28.7 billion in 2003. The distribution of the world latent demand (or potential industry earnings), however, is not be evenly distributed across regions. North America & the Caribbean is the largest market with $28.5 billion or 99.26 percent, followed by Asia with $0.1 billion or 0.32 percent, and then Europe with $0.1 billion or 0.25 percent of the world market. In essence, if firms target these top 3 regions, they cover come 99.83 percent of the global latent demand for biotechnology.

2.1 THE WORLDWIDE MARKET POTENTIAL FOR BIOTECHNOLOGY Worldwide Market Potential for Biotechnology (US $ mln): 2003 Region

Latent Demand US $ mln

% of Globe

_________________________________________________________________________________________________________

North America & the Caribbean Asia Europe Latin America Middle East Africa Oceana Total

28,490 91 72 23 12 11 4 28,702

99.3 0.3 0.3 0.1 0.0 0.0 0.0 100.0

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Worldwide Market Potential for Biotechnology (US $ mln): 2003

Asia Europe North America & the Caribbean

Latin America Other

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

20

World Market for Biotechnology: 1998 - 2008 Year

World Market US $ mln

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

17,863.34 19,637.85 21,589.54 23,736.12 26,098.04 28,701.69 31,566.35 34,717.11 38,182.55 41,994.12 46,186.41

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

21

3 AFRICA: BIOTECHNOLOGY 3.1

EXECUTIVE SUMMARY Market Potential for Biotechnology in Africa (US $ mln): 2003

Country

Latent Demand US $ mln

% of Africa

2 2 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 11

22.04% 14.90% 10.31% 7.01% 6.21% 3.79% 2.76% 2.69% 2.33% 2.23% 2.17% 1.69% 1.61% 1.59% 1.56% 1.54% 1.52% 1.15% 0.97% 0.75% 0.74% 0.72% 0.63% 0.61% 0.60% 7.88% 100.00%

_________________________________________________________________________________________________________

South Africa Egypt Algeria Nigeria Morocco Tunisia Libya Kenya Ethiopia Ghana Sudan Congo (formerly Zaire) Zimbabwe Uganda Cameroon Ivory coast Tanzania Mozambique Senegal Mauritius Madagascar Burkina Faso Botswana Angola Guinea Other Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

22

Market Potential for Biotechnology in Africa (US $ mln): 2003 Algeria

Nigeria

Egypt

Other South Africa

The Market for Biotechnology in Africa: 1998 - 2008 Year

US $ mln

% of Globe

9.28 9.54 9.82 10.11 10.46 11.11 11.85 12.65 13.50 14.41 15.39

0.05 0.05 0.05 0.04 0.04 0.04 0.04 0.04 0.04 0.03 0.03

_________________________________________________________________________________________________________

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

3.2

23

ALGERIA Biotechnology (US $ mln): Algeria 1998 - 2008

Year

Algeria

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

1 1 1 1 1 1 1 1 1 2 2

10.57% 10.49% 10.40% 10.32% 10.25% 10.31% 10.39% 10.47% 10.54% 10.61% 10.69%

0.01% 0.01% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Algeria: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

148 262 365 474 704 721 726 773 841 843 845 891 929

0.41 0.17 0.12 0.08 0.05 0.05 0.05 0.04 0.04 0.04 0.03 0.03 0.03 1.15

36.17 15.09 10.58 7.34 4.37 4.10 4.08 3.67 3.12 3.10 3.05 2.76 2.57 100.00

3.73 1.56 1.09 0.76 0.45 0.42 0.42 0.38 0.32 0.32 0.31 0.28 0.26 10.31

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Algiers Oran Constantine Annaba Batna Blida Setif Sidi-Bel-Abbes Ech-Cheliff Skikda Tlemcen Bejaia Bechar Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

3.3

24

ANGOLA Biotechnology (US $ mln): Angola 1998 - 2008

Year

Angola

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.62% 0.62% 0.61% 0.61% 0.61% 0.61% 0.61% 0.62% 0.62% 0.63% 0.63%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Angola: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

682 1,686 1,704 1,797 1,805 1,869 1,897

0.05 0.00 0.00 0.00 0.00 0.00 0.00 0.07

78.48 5.65 5.38 3.34 3.23 2.21 1.72 100.00

0.48 0.03 0.03 0.02 0.02 0.01 0.01 0.61

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Luanda Lubango Namibe Huambo Lobito Benguela Malanje Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

3.4

25

BENIN Biotechnology (US $ mln): Benin 1998 - 2008

Year

Benin

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.41% 0.40% 0.40% 0.40% 0.40% 0.40% 0.40% 0.40% 0.41% 0.41% 0.41%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Benin: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

1,002 1,373 1,726 1,766 1,770

0.02 0.01 0.00 0.00 0.00 0.04

56.24 24.02 7.62 6.24 5.89 100.00

0.22 0.10 0.03 0.02 0.02 0.40

0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Cotonou Porto-Novo Parakou Abomey Natitingou Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

3.5

26

BOTSWANA Biotechnology (US $ mln): Botswana 1998 - 2008

Year

Botswana

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.66% 0.65% 0.64% 0.63% 0.62% 0.63% 0.64% 0.65% 0.65% 0.66% 0.67%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Botswana: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

1,327 1,366 1,408 1,431 1,571 1,594 1,613 1,762 1,799 1,810 1,831 1,857 1,879

0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.07

17.02 15.49 14.26 13.04 8.28 7.52 7.06 3.99 3.22 3.07 2.76 2.30 1.99 100.00

0.11 0.10 0.09 0.08 0.05 0.05 0.04 0.03 0.02 0.02 0.02 0.01 0.01 0.63

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Gaborone Mahalapye Serowe Tutume Bobonong Francistown Selebi-Phikwe Lobatse Molepolole Kanye Mochudi Maun Ramotswa Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

3.6

27

BURKINA FASO Biotechnology (US $ mln): Burkina Faso 1998 - 2008

Year

Burkina Faso

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.74% 0.74% 0.73% 0.72% 0.72% 0.72% 0.73% 0.73% 0.74% 0.74% 0.75%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Burkina Faso: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

762 1,038 1,606 1,688 1,721 1,776

0.04 0.02 0.01 0.00 0.00 0.00 0.08

53.58 28.00 6.30 4.73 4.24 3.15 100.00

0.39 0.20 0.05 0.03 0.03 0.02 0.72

0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Ouagadougou Bobo-Dioulasso Koudougou Ouahigouya Banfora Kaya Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

3.7

28

BURUNDI Biotechnology (US $ mln): Burundi 1998 - 2008

Year

Burundi

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.25% 0.26% 0.26% 0.26% 0.26% 0.26% 0.26% 0.26% 0.26% 0.25% 0.25%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Burundi: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

1,069 1,514 1,976 2,006 2,025

0.02 0.01 0.00 0.00 0.00 0.03

70.91 24.68 2.08 1.30 1.04 100.00

0.19 0.06 0.01 0.00 0.00 0.26

0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Bujumbura Gitega Bururi Rumonge Ngozi Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

3.8

29

CAMEROON Biotechnology (US $ mln): Cameroon 1998 - 2008

Year

Cameroon

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

1.59% 1.58% 1.57% 1.56% 1.56% 1.56% 1.57% 1.58% 1.58% 1.59% 1.60%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Cameroon: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

496 693 1,477 1,490 1,504 1,586 1,678 1,718 1,748 1,788

0.08 0.05 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.17

46.52 29.65 4.66 4.41 4.25 3.17 2.25 2.00 1.71 1.37 100.00

0.73 0.46 0.07 0.07 0.07 0.05 0.04 0.03 0.03 0.02 1.56

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Douala Yaounde Nkongsamba Maroua Garoua Bafoussam Kumba Bamenda Foumban Limbe Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

3.9

30

CAPE VERDE Biotechnology (US $ mln): Cape Verde 1998 - 2008

Year

Cape Verde

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Cape Verde: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

1,781 1,841 2,056 2,063 2,064

0.00 0.00 0.00 0.00 0.00 0.00

54.95 40.66 2.20 1.10 1.10 100.00

0.02 0.02 0.00 0.00 0.00 0.04

0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Praia Mindelo Ribeira Grande Santa Maria Sal Rei Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

31

3.10 CENTRAL AFRICAN REPUBLIC Biotechnology (US $ mln): Central African Republic 1998 - 2008 Year

Central African Republic

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.37% 0.37% 0.37% 0.37% 0.37% 0.37% 0.37% 0.37% 0.37% 0.37% 0.37%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Central African Republic: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

954 1,633 1,771 1,786 1,852 1,885

0.03 0.00 0.00 0.00 0.00 0.00 0.04

68.70 11.51 6.33 5.98 4.14 3.34 100.00

0.25 0.04 0.02 0.02 0.02 0.01 0.37

0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Bangui Berberati Bouar Bambari Bangassou Mbaiki Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

32

3.11 CHAD Biotechnology (US $ mln): Chad 1998 - 2008 Year

Chad

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.49% 0.49% 0.49% 0.49% 0.49% 0.49% 0.49% 0.49% 0.49% 0.49% 0.49%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Chad: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

965 1,540 1,638 1,692 1,703 1,723 1,744 1,909 1,921

0.03 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.05

50.05 12.12 8.50 6.94 6.74 6.26 5.67 1.96 1.76 100.00

0.24 0.06 0.04 0.03 0.03 0.03 0.03 0.01 0.01 0.49

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

N'Djamena Sarh Moundou Abeche Bongor Doba Lai Koumra Kelo Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

33

3.12 COMOROS Biotechnology (US $ mln): Comoros 1998 - 2008 Year

Comoros

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Comoros: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

1,887 1,935 2,004 2,038

0.00 0.00 0.00 0.00 0.00

48.84 30.23 13.95 6.98 100.00

0.01 0.01 0.00 0.00 0.02

0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Moroni Mutsamudu Fomboni Mitsamiouli Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

34

3.13 CONGO (FORMERLY ZAIRE) Biotechnology (US $ mln): Congo (formerly Zaire) 1998 - 2008 Year

Congo (formerly Zaire)

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

1.25% 1.38% 1.52% 1.68% 1.81% 1.69% 1.55% 1.41% 1.29% 1.18% 1.08%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Congo (formerly Zaire): Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

440 1,094 1,222 1,392 1,407 1,530 1,560 1,561 1,576 1,599 1,604 1,649

0.09 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.19

50.00 10.23 7.97 5.48 5.33 3.65 3.24 3.22 3.01 2.77 2.73 2.35 100.00

0.85 0.17 0.14 0.09 0.09 0.06 0.05 0.05 0.05 0.05 0.05 0.04 1.69

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Kinshasa Lubumbashi Mbuji-Mayi Kananga Kisangani Likasi Kalemie Bukavu Kamina Kikwit Matadi Mbandaka Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

35

3.14 IVORY COAST Biotechnology (US $ mln): Ivory coast 1998 - 2008 Year

Ivory coast

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

1.45% 1.48% 1.51% 1.54% 1.56% 1.54% 1.51% 1.49% 1.46% 1.43% 1.41%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Cote d'Ivoire: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

350 1,215 1,468 1,584 1,664 1,690 1,701 1,751

0.13 0.02 0.01 0.01 0.00 0.00 0.00 0.00 0.17

74.60 8.87 4.84 3.23 2.42 2.22 2.14 1.69 100.00

1.15 0.14 0.07 0.05 0.04 0.03 0.03 0.03 1.54

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Abidjan Bouake Yamoussoukro Daloa Port-Bouet Man Korhogo Gagnoa Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

36

3.15 DJIBOUTI Biotechnology (US $ mln): Djibouti 1998 - 2008 Year

Djibouti

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Djibouti: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

1,777 2,003 2,024 2,026 2,027

0.00 0.00 0.00 0.00 0.00 0.00

66.67 10.11 8.05 7.82 7.36 100.00

0.02 0.00 0.00 0.00 0.00 0.03

0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Djibouti Dikhil Tadjourah Ali-Sabiah Obock Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

37

3.16 EGYPT Biotechnology (US $ mln): Egypt 1998 - 2008 Year

Egypt

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

1 1 1 2 2 2 2 2 2 2 2

15.27% 15.15% 15.03% 14.90% 14.81% 14.90% 15.01% 15.12% 15.23% 15.33% 15.44%

0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Egypt: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

80 196 297 850 855 866 883 893 979 1,006 1,020 1,136

0.99 0.26 0.15 0.03 0.03 0.03 0.03 0.03 0.03 0.02 0.02 0.02 1.65

59.57 15.80 9.05 2.09 2.07 2.03 1.94 1.91 1.58 1.48 1.44 1.06 100.00

8.87 2.35 1.35 0.31 0.31 0.30 0.29 0.28 0.23 0.22 0.21 0.16 14.90

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01

_________________________________________________________________________________________________________

Cairo Alexandria Giza Al-Mahallah al Kubra Port Said Tanta Al-Mansurah Helwan Asyut Zagazig Suez Aswan Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

38

3.17 EQUATORIAL GUINEA Biotechnology (US $ mln): Equatorial Guinea 1998 - 2008 Year

Equatorial Guinea

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.07% 0.07% 0.06% 0.06% 0.06% 0.06% 0.06% 0.06% 0.07% 0.07% 0.07%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Equatorial Guinea: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

1,740 1,867 1,898 1,932

0.00 0.00 0.00 0.00 0.01

47.24 22.83 17.32 12.60 100.00

0.03 0.01 0.01 0.01 0.06

0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Malabo Bata Luba Mbini Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

39

3.18 ETHIOPIA Biotechnology (US $ mln): Ethiopia 1998 - 2008 Year

Ethiopia

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

2.28% 2.30% 2.31% 2.33% 2.34% 2.33% 2.32% 2.30% 2.28% 2.27% 2.25%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Ethiopia: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

274 885 1,378 1,449 1,473 1,474 1,529 1,532 1,539 1,567 1,656

0.16 0.03 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.26

62.14 12.30 4.07 3.37 3.16 3.16 2.66 2.62 2.58 2.29 1.66 100.00

1.45 0.29 0.09 0.08 0.07 0.07 0.06 0.06 0.06 0.05 0.04 2.33

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Addis Ababa Asmera Dire Dawa Gondar Dessye Nazret Jimma Harar Mekele Bahr Dar Debre Markos Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

40

3.19 GABON Biotechnology (US $ mln): Gabon 1998 - 2008 Year

Gabon

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.44% 0.45% 0.45% 0.46% 0.46% 0.46% 0.45% 0.45% 0.44% 0.44% 0.43%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Gabon: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

908 1,247 1,808 1,883 1,891 1,896

0.03 0.01 0.00 0.00 0.00 0.00 0.05

60.07 27.99 4.27 2.73 2.56 2.39 100.00

0.27 0.13 0.02 0.01 0.01 0.01 0.46

0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Libreville Port Gentil Lambarene Mouila Tchibanga Oyem Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

41

3.20 GHANA Biotechnology (US $ mln): Ghana 1998 - 2008 Year

Ghana

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

2.22% 2.22% 2.23% 2.23% 2.24% 2.23% 2.23% 2.23% 2.22% 2.22% 2.21%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Ghana: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

359 705 1,090 1,252 1,274 1,494 1,495 1,609 1,618 1,666

0.12 0.05 0.02 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.25

49.30 20.00 7.84 5.66 5.40 3.06 3.06 2.03 1.97 1.66 100.00

1.10 0.45 0.18 0.13 0.12 0.07 0.07 0.05 0.04 0.04 2.23

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Accra Kumasi Tamale Tema Sekondi-Takoradi Cape Coast Koforidua Sunyani Ho Bolgatanga Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

42

3.21 GUINEA Biotechnology (US $ mln): Guinea 1998 - 2008 Year

Guinea

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.62% 0.61% 0.61% 0.60% 0.60% 0.60% 0.61% 0.61% 0.62% 0.62% 0.62%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Guinea: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

678 1,534 1,614 1,847

0.05 0.01 0.00 0.00 0.07

79.93 10.09 7.37 2.61 100.00

0.48 0.06 0.04 0.02 0.60

0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Conakry Kankan Labe Nzerekore Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

43

3.22 GUINEA-BISSAU Biotechnology (US $ mln): Guinea-Bissau 1998 - 2008 Year

Guinea-Bissau

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.07% 0.07% 0.07% 0.07% 0.07% 0.07% 0.07% 0.07% 0.07% 0.07% 0.07%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Guinea-Bissau: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

1,577 1,979 2,013 2,032 2,033 2,034 2,039

0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.01

75.76 7.88 4.85 3.03 3.03 3.03 2.42 100.00

0.05 0.01 0.00 0.00 0.00 0.00 0.00 0.07

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Bissau Bafata Gabu Mansoa Catio Cantchungo Farim Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

44

3.23 KENYA Biotechnology (US $ mln): Kenya 1998 - 2008 Year

Kenya

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

2.56% 2.60% 2.65% 2.69% 2.72% 2.69% 2.65% 2.61% 2.58% 2.54% 2.50%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Kenya: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

270 601 998 1,207 1,435 1,556 1,590 1,798 1,814 1,845 1,855

0.17 0.06 0.03 0.02 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.30

55.53 21.43 8.40 5.13 3.02 2.06 1.81 0.75 0.70 0.60 0.55 100.00

1.49 0.58 0.23 0.14 0.08 0.06 0.05 0.02 0.02 0.02 0.01 2.69

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Nairobi Mombasa Kisumu Nakuru Eldoret Thika Nyeri Nanyuki Kitale Malindi Kericho Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

45

3.24 LESOTHO Biotechnology (US $ mln): Lesotho 1998 - 2008 Year

Lesotho

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.30% 0.30% 0.30% 0.30% 0.30% 0.30% 0.30% 0.30% 0.30% 0.30% 0.30%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Lesotho: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

936 1,813 1,863 1,890

0.03 0.00 0.00 0.00 0.03

85.16 6.25 4.69 3.91 100.00

0.26 0.02 0.01 0.01 0.30

0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Maseru Teyateyaneng Leribe Mafeteng Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

46

3.25 LIBERIA Biotechnology (US $ mln): Liberia 1998 - 2008 Year

Liberia

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.25% 0.24% 0.23% 0.21% 0.20% 0.21% 0.22% 0.24% 0.25% 0.26% 0.28%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Liberia: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

1,112 1,754 1,911 1,971 1,988

0.02 0.00 0.00 0.00 0.00 0.02

78.41 12.18 4.43 2.77 2.21 100.00

0.17 0.03 0.01 0.01 0.00 0.21

0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Monrovia Harbel Buchanan Tubmanburg Harper Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

47

3.26 LIBYA Biotechnology (US $ mln): Libya 1998 - 2008 Year

Libya

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

2.89% 2.85% 2.80% 2.76% 2.73% 2.76% 2.80% 2.84% 2.88% 2.92% 2.96%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Libya: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

283 492 1,042 1,202 1,570 1,578 1,588 1,593 1,605 1,641

0.16 0.08 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.00 0.31

50.89 26.45 7.24 5.04 1.90 1.84 1.78 1.72 1.66 1.48 100.00

1.40 0.73 0.20 0.14 0.05 0.05 0.05 0.05 0.05 0.04 2.76

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Tripoli Benghazi Misurata Az Zawiyah Al-Bayda Ajdabiya Darnah Sebha Tubruq Al-Marj Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

48

3.27 MADAGASCAR Biotechnology (US $ mln): Madagascar 1998 - 2008 Year

Madagascar

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.76% 0.75% 0.75% 0.74% 0.74% 0.74% 0.75% 0.75% 0.76% 0.76% 0.76%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Madagascar: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

732 1,432 1,510 1,511 1,601 1,683 1,717

0.05 0.01 0.01 0.01 0.01 0.00 0.00 0.08

56.02 11.08 8.84 8.84 6.29 4.70 4.22 100.00

0.42 0.08 0.07 0.07 0.05 0.03 0.03 0.74

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Antananarivo Toamasina Mahajanga Fianarantsoa Antsirabe Toliara Antsiranana Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

49

3.28 MALAWI Biotechnology (US $ mln): Malawi 1998 - 2008 Year

Malawi

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.56% 0.56% 0.56% 0.56% 0.56% 0.56% 0.56% 0.56% 0.56% 0.56% 0.56%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Malawi: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

899 1,166 1,447 1,669 1,914 1,931

0.03 0.02 0.01 0.00 0.00 0.00 0.06

49.45 26.99 14.11 6.50 1.60 1.35 100.00

0.28 0.15 0.08 0.04 0.01 0.01 0.56

0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Blantyre Lilongwe Mzuzu Zomba Karonga Nkhotakota Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

50

3.29 MALI Biotechnology (US $ mln): Mali 1998 - 2008 Year

Mali

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.56% 0.56% 0.55% 0.55% 0.55% 0.55% 0.55% 0.56% 0.56% 0.56% 0.57%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Mali: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

759 1,653 1,708 1,738 1,747 1,815 1,888

0.04 0.00 0.00 0.00 0.00 0.00 0.00 0.06

71.15 7.16 5.95 5.18 4.96 3.41 2.20 100.00

0.39 0.04 0.03 0.03 0.03 0.02 0.01 0.55

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Bamako Segou Mopti Sikasso Kayes Gao Timbuktu Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

51

3.30 MAURITANIA Biotechnology (US $ mln): Mauritania 1998 - 2008 Year

Mauritania

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.33% 0.33% 0.33% 0.33% 0.32% 0.33% 0.33% 0.33% 0.33% 0.34% 0.34%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Mauritania: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

918 1,889 1,892 1,912 1,916 1,917 1,967

0.03 0.00 0.00 0.00 0.00 0.00 0.00 0.04

82.92 3.65 3.48 2.82 2.65 2.65 1.82 100.00

0.27 0.01 0.01 0.01 0.01 0.01 0.01 0.33

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Nouakchott Nouadhibou Kaedi Zouerate Rosso Atar Kiffa Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

52

3.31 MAURITIUS Biotechnology (US $ mln): Mauritius 1998 - 2008 Year

Mauritius

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.80% 0.78% 0.77% 0.75% 0.74% 0.75% 0.77% 0.78% 0.79% 0.81% 0.82%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Mauritius: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

957 1,108 1,285 1,286 1,357

0.03 0.02 0.01 0.01 0.01 0.08

33.33 22.30 15.59 15.59 13.19 100.00

0.25 0.17 0.12 0.12 0.10 0.75

0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Port Louis Beau Bassin Quatre Bornes Curepipe Vacoas-Phoenix Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

53

3.32 MOROCCO Biotechnology (US $ mln): Morocco 1998 - 2008 Year

Morocco

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

1 1 1 1 1 1 1 1 1 1 1

5.95% 6.04% 6.12% 6.20% 6.26% 6.21% 6.13% 6.06% 5.98% 5.90% 5.83%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Morocco: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

266 478 540 666 690 708 723 730 784 787 923

0.17 0.08 0.08 0.05 0.05 0.05 0.05 0.05 0.04 0.04 0.03 0.69

24.65 12.09 10.92 7.92 7.60 7.07 6.79 6.73 5.97 5.94 4.32 100.00

1.53 0.75 0.68 0.49 0.47 0.44 0.42 0.42 0.37 0.37 0.27 6.21

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Casablanca Marrakech Rabat Fez Oujda Kenitra Tetouan Safi Meknes Agadir Tangier Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

54

3.33 MOZAMBIQUE Biotechnology (US $ mln): Mozambique 1998 - 2008 Year

Mozambique

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

1.15% 1.15% 1.15% 1.15% 1.14% 1.15% 1.15% 1.15% 1.15% 1.15% 1.15%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Mozambique: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

522 1,058 1,244 1,505 1,731 1,837 1,838

0.08 0.02 0.01 0.01 0.00 0.00 0.00 0.13

60.83 16.60 11.20 5.80 2.62 1.48 1.48 100.00

0.70 0.19 0.13 0.07 0.03 0.02 0.02 1.15

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Maputo Beira Nampula Nacala Machaze Mandie Chibuto Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

55

3.34 NAMIBIA Biotechnology (US $ mln): Namibia 1998 - 2008 Year

Namibia

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.46% 0.46% 0.46% 0.46% 0.46% 0.46% 0.46% 0.46% 0.46% 0.46% 0.46%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Namibia: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

840 1,670 1,720 1,760 1,780 1,806

0.04 0.00 0.00 0.00 0.00 0.00 0.05

70.55 7.98 6.75 5.52 4.91 4.29 100.00

0.32 0.04 0.03 0.03 0.02 0.02 0.46

0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Windhoek Tsumeb Keetmanshoop Otjiwarongo Luderitz Swakopmund Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

56

3.35 NIGER Biotechnology (US $ mln): Niger 1998 - 2008 Year

Niger

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.60% 0.60% 0.60% 0.60% 0.60% 0.60% 0.60% 0.60% 0.60% 0.60% 0.60%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Niger: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

783 1,452 1,536 1,654 1,761 1,854 1,901

0.04 0.01 0.01 0.00 0.00 0.00 0.00 0.07

61.99 12.93 10.12 6.54 4.21 2.49 1.71 100.00

0.37 0.08 0.06 0.04 0.03 0.01 0.01 0.60

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Niamey Zinder Maradi Tahoua Agadez Birni N'Konni Filingue Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

57

3.36 NIGERIA Biotechnology (US $ mln): Nigeria 1998 - 2008 Year

Nigeria

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

1 1 1 1 1 1 1 1 1 1 1

7.01% 7.01% 7.01% 7.01% 7.00% 7.01% 7.01% 7.01% 7.01% 7.01% 7.01%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Nigeria: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

330 354 603 640 777 778 824 839 870 871 876 919 959 978 1,076

0.13 0.13 0.06 0.06 0.04 0.04 0.04 0.04 0.03 0.03 0.03 0.03 0.03 0.03 0.02 0.04 0.78

17.07 16.09 8.20 7.57 5.37 5.35 4.81 4.60 4.26 4.26 4.18 3.85 3.55 3.36 2.59 4.90 100.00

1.20 1.13 0.57 0.53 0.38 0.38 0.34 0.32 0.30 0.30 0.29 0.27 0.25 0.24 0.18 0.34 7.01

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Lagos Ibadan Ogbomosho Kano Oshogbo Ilorin Abeokuta Port Harcourt Ilesha Zaria Onitsha Kaduna Enugu Aba Benin City Others Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

58

3.37 REPUBLIC OF CONGO Biotechnology (US $ mln): Republic of Congo 1998 - 2008 Year

Republic of Congo

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.19% 0.19% 0.19% 0.19% 0.19% 0.19% 0.19% 0.19% 0.19% 0.19% 0.19%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Republic of Congo: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

1,318 1,563 1,939 1,948 1,993 2,023 2,030

0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.02

58.32 29.16 3.72 3.62 2.45 1.57 1.17 100.00

0.11 0.05 0.01 0.01 0.00 0.00 0.00 0.19

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Brazzaville Pointe-Noire Nkayi Loubomo Ngamaba-Mfilou Loandjili Mossendjo Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

59

3.38 REUNION Biotechnology (US $ mln): Reunion 1998 - 2008 Year

Reunion

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.21% 0.20% 0.20% 0.20% 0.20% 0.20% 0.20% 0.20% 0.20% 0.21% 0.21%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Reunion: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

1,503 1,650 1,709 1,750 1,796 1,816

0.01 0.00 0.00 0.00 0.00 0.00 0.02

32.61 19.41 15.90 12.94 9.97 9.16 100.00

0.07 0.04 0.03 0.03 0.02 0.02 0.20

0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Saint-Denis Saint-Paul Saint-Pierre Le Tampon Saint-Louis Le Port Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

60

3.39 RWANDA Biotechnology (US $ mln): Rwanda 1998 - 2008 Year

Rwanda

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.40% 0.40% 0.39% 0.39% 0.38% 0.39% 0.39% 0.40% 0.40% 0.40% 0.41%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Rwanda: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

917 1,658 1,745 1,793 1,834 1,866

0.03 0.00 0.00 0.00 0.00 0.00 0.04

69.78 9.78 7.11 5.33 4.44 3.56 100.00

0.27 0.04 0.03 0.02 0.02 0.01 0.39

0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Kigali Butare Ruhengeri Gisenyi Nyabisindu Cyangugu Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

61

3.40 SAO TOME E PRINCIPE Biotechnology (US $ mln): Sao Tome E Principe 1998 - 2008 Year

Sao Tome E Principe

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Sao Tome E Principe: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

1,900 2,065

0.00 0.00 0.00

97.22 2.78 100.00

0.01 0.00 0.01

0.00 0.00 0.00

_________________________________________________________________________________________________________

Sao Tome Santo Antonio Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

3.41 SENEGAL Biotechnology (US $ mln): Senegal 1998 - 2008 Year

Senegal

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

1.00% 0.99% 0.98% 0.97% 0.96% 0.97% 0.98% 0.99% 1.00% 1.01% 1.02%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

62

Senegal: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

524 1,450 1,507 1,565 1,591 1,743

0.08 0.01 0.01 0.01 0.01 0.00 0.11

71.64 8.09 6.84 5.55 5.03 2.85 100.00

0.69 0.08 0.07 0.05 0.05 0.03 0.97

0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Dakar Thies Kaolack Zinguinchor Saint-Louis Diourbel Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

3.42 SIERRA LEONE Biotechnology (US $ mln): Sierra Leone 1998 - 2008 Year

Sierra Leone

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.16% 0.16% 0.16% 0.16% 0.16% 0.16% 0.16% 0.16% 0.16% 0.16% 0.16%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Sierra Leone: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

1,190 1,927 1,998 2,001 2,036 2,037

0.02 0.00 0.00 0.00 0.00 0.00 0.02

88.18 4.88 2.44 2.25 1.13 1.13 100.00

0.14 0.01 0.00 0.00 0.00 0.00 0.16

0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Freetown Bo Kenema Makeni Bonthe Port Loko Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

63

3.43 SOMALIA Biotechnology (US $ mln): Somalia 1998 - 2008 Year

Somalia

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.25% 0.25% 0.25% 0.26% 0.26% 0.26% 0.25% 0.25% 0.25% 0.25% 0.25%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Somalia: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

1,315 1,623 1,705 1,706 1,787 1,930 1,952 2,046

0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.03

42.66 17.06 12.80 12.80 8.53 2.99 2.56 0.60 100.00

0.11 0.04 0.03 0.03 0.02 0.01 0.01 0.00 0.26

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Mogadishu Hargeysa Burao Baidoa Kismaayo Berbera Marka Giohar Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

64

3.44 SOUTH AFRICA Biotechnology (US $ mln): South Africa 1998 - 2008 Year

South Africa

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

2 2 2 2 2 2 3 3 3 3 3

21.89% 21.95% 22.00% 22.04% 22.07% 22.04% 22.00% 21.96% 21.91% 21.86% 21.80%

0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

South Africa: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

96 110 115 267 668 744 768 896 1,019 1,026 1,050 1,208

0.77 0.64 0.61 0.17 0.05 0.04 0.04 0.03 0.02 0.02 0.02 0.02 2.45

31.46 26.26 24.90 6.93 2.21 1.82 1.73 1.27 0.97 0.95 0.88 0.63 100.00

6.93 5.79 5.49 1.53 0.49 0.40 0.38 0.28 0.21 0.21 0.19 0.14 22.04

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01

_________________________________________________________________________________________________________

Johannesburg Cape Town Pretoria Durban Roodepoort Germiston Boksburg Umlazi Bloemfontein Pietermaritzburg Port Elizabeth East London Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

65

3.45 SUDAN Biotechnology (US $ mln): Sudan 1998 - 2008 Year

Sudan

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

2.30% 2.26% 2.22% 2.18% 2.15% 2.17% 2.21% 2.25% 2.28% 2.32% 2.36%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Sudan: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

555 589 928 1,093 1,100 1,254 1,266 1,446

0.07 0.06 0.03 0.02 0.02 0.01 0.01 0.01 0.24

29.89 26.85 12.24 8.01 7.90 5.81 5.64 3.67 100.00

0.65 0.58 0.27 0.17 0.17 0.13 0.12 0.08 2.17

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Omdurman Khartoum Port Sudan Wadi Medani Al Obeid Atbara Kassala Kosti Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

66

3.46 SWAZILAND Biotechnology (US $ mln): Swaziland 1998 - 2008 Year

Swaziland

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.26% 0.26% 0.26% 0.26% 0.26% 0.26% 0.26% 0.26% 0.26% 0.26% 0.26%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Swaziland: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

1,264 1,549 1,716 1,784 1,877 1,910 1,959

0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.03

46.99 21.69 12.05 8.43 4.82 3.61 2.41 100.00

0.12 0.06 0.03 0.02 0.01 0.01 0.01 0.26

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Mbabane Manzini Big Bend Mhlume Nhlangano Pigg's Peak Siteki Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

67

3.47 TANZANIA Biotechnology (US $ mln): Tanzania 1998 - 2008 Year

Tanzania

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

1.56% 1.54% 1.53% 1.52% 1.51% 1.52% 1.53% 1.54% 1.55% 1.57% 1.58%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Tanzania: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

425 1,256 1,259 1,288 1,416 1,458 1,528 1,572

0.10 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.17

57.47 8.30 8.22 7.70 5.75 5.01 4.11 3.44 100.00

0.87 0.13 0.12 0.12 0.09 0.08 0.06 0.05 1.52

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Dar es Salaam Mwanza Zanzibar Tanga Mbeya Tabora Arusha Dodoma Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

68

3.48 THE GAMBIA Biotechnology (US $ mln): The Gambia 1998 - 2008 Year

The Gambia

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.09% 0.09% 0.09% 0.09% 0.09% 0.09% 0.09% 0.09% 0.09% 0.09% 0.09%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

The Gambia: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

1,625 1,820 1,923 1,926 1,996 2,020 2,021 2,052 2,053

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01

47.69 20.37 9.26 8.80 4.63 3.24 3.24 1.39 1.39 100.00

0.04 0.02 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.09

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Serrekunda Banjul Brikama Bakau Farefenni Gunjur Sukuta Georgetown Basse Santa Su Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

69

3.49 TOGO Biotechnology (US $ mln): Togo 1998 - 2008 Year

Togo

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.44% 0.44% 0.44% 0.44% 0.44% 0.44% 0.44% 0.44% 0.44% 0.44% 0.44%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Togo: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

884 1,659 1,758 1,790 1,832 1,870 1,894 1,902 1,928 1,999

0.03 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.05

66.06 8.66 5.78 4.87 3.97 3.07 2.53 2.35 1.81 0.90 100.00

0.29 0.04 0.03 0.02 0.02 0.01 0.01 0.01 0.01 0.00 0.44

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Lome Sokodé Palimé Atakpamé Bassari Tsévié Anécho Mango Bafilo Tabligbo Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

70

3.50 TUNISIA Biotechnology (US $ mln): Tunisia 1998 - 2008 Year

Tunisia

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 1 1 1

3.88% 3.85% 3.82% 3.79% 3.77% 3.79% 3.82% 3.84% 3.87% 3.90% 3.92%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Tunisia: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

268 582 950 969 982 983 1,018 1,071 1,138 1,151

0.17 0.07 0.03 0.03 0.03 0.03 0.02 0.02 0.02 0.02 0.42

40.17 15.61 6.66 6.39 6.19 6.19 5.65 4.85 4.17 4.10 100.00

1.52 0.59 0.25 0.24 0.23 0.23 0.21 0.18 0.16 0.16 3.79

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Tunis Sfax Ariana Bizerte Djerba Gabes Sousse Kairouan La Goulette Gafsa Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

71

3.51 UGANDA Biotechnology (US $ mln): Uganda 1998 - 2008 Year

Uganda

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

1.65% 1.63% 1.61% 1.59% 1.57% 1.59% 1.61% 1.63% 1.65% 1.66% 1.68%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Uganda: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

355 1,238 1,483 1,493 1,553 1,575 1,619 1,620

0.12 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.18

70.72 8.17 4.47 4.31 3.54 3.24 2.77 2.77 100.00

1.12 0.13 0.07 0.07 0.06 0.05 0.04 0.04 1.59

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Kampala Jinja Masaka Mbale Mbarara Entebbe Gulu Tororo Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

72

3.52 WESTERN SAHARA Biotechnology (US $ mln): Western Sahara 1998 - 2008 Year

Western Sahara

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Western Sahara: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

2,015 2,061 2,062

0.00 0.00 0.00 0.00

72.31 13.85 13.85 100.00

0.00 0.00 0.00 0.00

0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Laayoune Dakhla Semara Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

73

3.53 ZAMBIA Biotechnology (US $ mln): Zambia 1998 - 2008 Year

Zambia

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.51% 0.51% 0.51% 0.51% 0.51% 0.51% 0.51% 0.51% 0.51% 0.52% 0.52%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Zambia: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

1,140 1,424 1,443 1,672 1,673 1,681 1,730 1,825 1,835 1,856

0.02 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.06

30.87 16.75 15.72 7.10 7.06 6.88 5.89 3.48 3.34 2.91 100.00

0.16 0.09 0.08 0.04 0.04 0.04 0.03 0.02 0.02 0.01 0.51

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Lusaka Kitwe Ndola Kabwe Mufulira Chingola Luanshya Livingstone Kalulushi Chililabombwe Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

74

3.54 ZIMBABWE Biotechnology (US $ mln): Zimbabwe 1998 - 2008 Year

Zimbabwe

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

1.38% 1.45% 1.53% 1.61% 1.67% 1.61% 1.54% 1.47% 1.41% 1.34% 1.28%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Zimbabwe: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

559 740 1,054 1,466 1,506 1,608 1,630 1,667 1,734 1,755 1,756 1,778

0.07 0.05 0.02 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.18

40.01 25.21 11.87 4.64 4.11 2.82 2.64 2.29 1.82 1.59 1.59 1.41 100.00

0.64 0.41 0.19 0.07 0.07 0.05 0.04 0.04 0.03 0.03 0.03 0.02 1.61

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Harare Bulawayo Chitungwiza Gweru Mutare Kwekwe Kadoma Hwange Masvingo Chegutu Zvishavane Chinhoyi Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

75

4 ASIA: BIOTECHNOLOGY 4.1

EXECUTIVE SUMMARY Market Potential for Biotechnology in Asia (US $ mln): 2003

Country

Latent Demand US $ mln

% of Asia

31 21 15 5 4 3 3 2 2 1 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 91

33.93% 22.80% 16.28% 5.74% 4.81% 3.03% 2.86% 2.27% 1.68% 1.50% 1.36% 1.14% 0.83% 0.47% 0.46% 0.25% 0.16% 0.12% 0.09% 0.07% 0.06% 0.04% 0.03% 0.02% 0.00% 0.00% 100.00%

_________________________________________________________________________________________________________

China Japan India South Korea Indonesia Thailand Taiwan Philippines Malaysia Bangladesh Hong Kong Vietnam Singapore Burma Sri Lanka Nepal North Korea Cambodia Papua New Guinea Laos Macau Brunei Mongolia Bhutan Maldives Other Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

76

Market Potential for Biotechnology in Asia (US $ mln): 2003 India South Korea

Japan

Other China

The Market for Biotechnology in Asia: 1998 - 2008 Year

US $ mln

% of Globe

70.23 73.32 76.64 80.21 84.39 90.94 98.39 106.47 115.25 124.78 135.13

0.39 0.37 0.35 0.34 0.32 0.32 0.31 0.31 0.30 0.30 0.29

_________________________________________________________________________________________________________

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

4.2

77

BANGLADESH Biotechnology (US $ mln): Bangladesh 1998 - 2008

Year

Bangladesh

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

1 1 1 1 1 1 1 2 2 2 2

1.67% 1.63% 1.59% 1.55% 1.51% 1.50% 1.49% 1.48% 1.47% 1.47% 1.46%

0.01% 0.01% 0.01% 0.01% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Bangladesh: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

119 210 284 587 617 735 751 779 793 831 838 907

0.57 0.24 0.16 0.07 0.06 0.05 0.04 0.04 0.04 0.04 0.04 0.03 1.36

41.79 17.31 11.41 4.79 4.49 3.37 3.25 3.06 2.97 2.70 2.63 2.24 100.00

0.63 0.26 0.17 0.07 0.07 0.05 0.05 0.05 0.04 0.04 0.04 0.03 1.50

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Dhaka Chittagong Khulna Narayanganj Rajshahi Mymensingh Comilla Barisal Sylhet Rangpur Jessore Saidpur Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

4.3

78

BHUTAN Biotechnology (US $ mln): Bhutan 1998 - 2008

Year

Bhutan

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Bhutan: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

1,676 1,694 1,772 1,809 1,827 1,977 1,978

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.02

25.32 24.05 16.46 13.92 12.66 3.80 3.80 100.00

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.02

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Thimphu Taga Dzong Punakha Bumthang Phuntsholing Tongsa Dzong Paro Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

4.4

79

BRUNEI Biotechnology (US $ mln): Brunei 1998 - 2008

Year

Brunei

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.05% 0.05% 0.05% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Brunei: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

1,052 1,409 1,485

0.02 0.01 0.01 0.04

54.74 25.26 20.00 100.00

0.02 0.01 0.01 0.04

0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Bandar Seri Begawan Seria Kuala Belait Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

4.5

80

BURMA Biotechnology (US $ mln): Burma 1998 - 2008

Year

Burma

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 1 1 1

0.52% 0.51% 0.50% 0.48% 0.47% 0.47% 0.47% 0.46% 0.46% 0.46% 0.45%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Burma: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

191 637 1,008 1,168 1,188 1,319 1,320 1,326

0.27 0.06 0.02 0.02 0.02 0.01 0.01 0.01 0.43

64.22 13.92 5.75 3.92 3.76 2.82 2.82 2.79 100.00

0.30 0.07 0.03 0.02 0.02 0.01 0.01 0.01 0.47

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Yangon Mandalay Moulmein Pegu Bassein Taunggye Sittwe Monywa Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

4.6

81

CAMBODIA Biotechnology (US $ mln): Cambodia 1998 - 2008

Year

Cambodia

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.13% 0.13% 0.12% 0.12% 0.12% 0.12% 0.12% 0.12% 0.11% 0.11% 0.11%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Cambodia: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

477 1,021

0.08 0.02 0.11

77.88 22.12 100.00

0.09 0.03 0.12

0.00 0.00 0.00

_________________________________________________________________________________________________________

Bhnom Penh Kompong Cham Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

4.7

CHINA Biotechnology (US $ mln): China 1998 - 2008

Year

China

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

19 21 23 26 28 31 34 37 41 45 50

27.28% 28.75% 30.25% 31.80% 33.24% 33.93% 34.50% 35.07% 35.64% 36.21% 36.78%

0.11% 0.11% 0.11% 0.11% 0.11% 0.11% 0.11% 0.11% 0.11% 0.11% 0.11%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

82

China: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

44 45 48 49 50 55 61 62 63 66 68 70 71 76 93

4.42 3.68 3.12 2.84 2.62 2.26 1.49 1.48 1.47 1.37 1.26 1.20 1.19 1.13 0.78 0.54 30.86

14.32 11.93 10.10 9.21 8.48 7.33 4.84 4.80 4.78 4.43 4.07 3.89 3.85 3.66 2.54 1.76 100.00

4.86 4.05 3.43 3.13 2.88 2.49 1.64 1.63 1.62 1.50 1.38 1.32 1.31 1.24 0.86 0.60 33.93

0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.11

_________________________________________________________________________________________________________

Shanghai Beijing Chongqing Guangzhou Chengdu Tianjin Harbin Nanjing Wuhan Jinan Shenyang Changchun Xi'an Dalian Shenzhen Others Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

4.8

HONG KONG Biotechnology (US $ mln): Hong Kong 1998 - 2008

Year

Hong Kong

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

1 1 1 1 1 1 1 2 2 2 2

1.63% 1.56% 1.48% 1.41% 1.35% 1.36% 1.39% 1.41% 1.43% 1.46% 1.48%

0.01% 0.01% 0.01% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

83

Hong Kong: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

69

1.24 1.24

100.00 100.00

1.36 1.36

0.00 0.00

_________________________________________________________________________________________________________

Hong Kong Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

4.9

INDIA Biotechnology (US $ mln): India 1998 - 2008

Year

India

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

13 13 13 13 14 15 16 17 19 20 22

18.33% 17.83% 17.33% 16.82% 16.37% 16.28% 16.25% 16.22% 16.19% 16.14% 16.10%

0.07% 0.07% 0.06% 0.06% 0.05% 0.05% 0.05% 0.05% 0.05% 0.05% 0.05%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

84

India: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

53 59 72 75 78 81 82 88 89 108 109 134 142 163 169

2.55 1.75 1.18 1.14 1.02 0.92 0.92 0.84 0.83 0.65 0.65 0.47 0.43 0.37 0.34 0.73 14.81

17.25 11.84 7.99 7.68 6.89 6.23 6.22 5.65 5.64 4.41 4.38 3.15 2.93 2.50 2.31 4.94 100.00

2.81 1.93 1.30 1.25 1.12 1.01 1.01 0.92 0.92 0.72 0.71 0.51 0.48 0.41 0.38 0.80 16.28

0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.05

_________________________________________________________________________________________________________

Maharashtra State Uttar Pradesh State West Bengal State Andhra Pradesh State Tamil Nadu State Gujarat State Madhya Pradesh State Karnataka State Bihar State Rajasthan State Punjab State Haryana State Kerala State Orissa State Union Territories Others Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

4.10 INDONESIA Biotechnology (US $ mln): Indonesia 1998 - 2008 Year

Indonesia

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

4 4 4 4 4 4 5 5 5 6 6

5.32% 5.21% 5.09% 4.97% 4.86% 4.81% 4.78% 4.74% 4.70% 4.67% 4.63%

0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.01% 0.01% 0.01% 0.01% 0.01%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

85

Indonesia: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

92 105 106 139 206 235 281 293 340 414 488 503 515 535 562

0.79 0.70 0.67 0.45 0.25 0.20 0.16 0.15 0.13 0.10 0.08 0.08 0.08 0.08 0.07 0.39 4.38

18.11 15.94 15.31 10.34 5.62 4.58 3.58 3.46 2.97 2.35 1.86 1.83 1.78 1.72 1.63 8.91 100.00

0.87 0.77 0.74 0.50 0.27 0.22 0.17 0.17 0.14 0.11 0.09 0.09 0.09 0.08 0.08 0.43 4.81

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.02

_________________________________________________________________________________________________________

Jawa Barat DKI jakarta Jawa Timur Jawa Tengah Sumatra Utara Riau Kalimentan Timur Sumatra Selatan Daerah Istimerwa Aceh Sulawesi Selatan Sumatra Barat Lampung Kalimantan Barat Bali Irian Jaya Others Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

4.11 JAPAN Biotechnology (US $ mln): Japan 1998 - 2008 Year

Japan

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

17 17 18 19 20 21 22 23 24 26 27

23.83% 23.75% 23.65% 23.51% 23.30% 22.80% 22.26% 21.73% 21.21% 20.70% 20.20%

0.09% 0.09% 0.08% 0.08% 0.08% 0.07% 0.07% 0.07% 0.06% 0.06% 0.06%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

86

Japan: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

46 64 91 97 122 132 136 143 151 154 176 177 195 202 215

3.47 1.41 0.80 0.77 0.55 0.50 0.46 0.43 0.41 0.39 0.33 0.33 0.27 0.26 0.22 10.14 20.73

16.75 6.79 3.88 3.70 2.66 2.41 2.20 2.09 1.97 1.88 1.59 1.58 1.29 1.23 1.08 48.89 100.00

3.82 1.55 0.89 0.84 0.61 0.55 0.50 0.48 0.45 0.43 0.36 0.36 0.30 0.28 0.25 11.15 22.80

0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.04 0.07

_________________________________________________________________________________________________________

Tokyo (23-wards) Yokohama Nagoya Osaka Sapporo Kawasaki Kyoto Kobe Fukuoka Hiroshima Chiba Sendai Kitakyushu Sakai Sagamihara Others Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

4.12 LAOS Biotechnology (US $ mln): Laos 1998 - 2008 Year

Laos

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.07% 0.07% 0.07% 0.07% 0.07% 0.07% 0.07% 0.06% 0.06% 0.06% 0.06%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

87

Laos: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

780 1,579 1,611 1,622 1,865 1,873

0.04 0.01 0.00 0.00 0.00 0.00 0.06

69.30 9.38 8.27 8.09 2.57 2.39 100.00

0.05 0.01 0.01 0.01 0.00 0.00 0.07

0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Vientiane Savannakhet Pakse Luang Prabang Sayaboury Khammouane Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

4.13 MACAU Biotechnology (US $ mln): Macau 1998 - 2008 Year

Macau

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.06% 0.06% 0.06% 0.06% 0.06% 0.06% 0.06% 0.05% 0.05% 0.05% 0.05%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Macau: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

710 1,791 1,960

0.05 0.00 0.00 0.05

94.12 4.52 1.36 100.00

0.05 0.00 0.00 0.06

0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Macau Taipa Coloane Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

88

4.14 MALAYSIA Biotechnology (US $ mln): Malaysia 1998 - 2008 Year

Malaysia

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

1 1 1 1 1 2 2 2 2 2 2

1.96% 1.89% 1.81% 1.73% 1.67% 1.68% 1.69% 1.71% 1.73% 1.74% 1.76%

0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Malaysia: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

172 392 429 463 541 556 560 577 583 592 593 616 645 672 675

0.34 0.11 0.10 0.09 0.07 0.07 0.07 0.07 0.07 0.06 0.06 0.06 0.06 0.05 0.05 0.18 1.52

22.08 7.38 6.34 5.71 4.92 4.72 4.70 4.41 4.31 4.24 4.23 4.02 3.83 3.53 3.52 12.06 100.00

0.37 0.12 0.11 0.10 0.08 0.08 0.08 0.07 0.07 0.07 0.07 0.07 0.06 0.06 0.06 0.20 1.68

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01

_________________________________________________________________________________________________________

Kuala Lumpur Ipoh Johor Baharu Melaka Petaling Jaya Tawai Kelang Kuala Terengganu Sandakan Kota Baharu George Town Kota Kinabalu Kuantan Taiping Seremban Others Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

89

4.15 MALDIVES Biotechnology (US $ mln): Maldives 1998 - 2008 Year

Maldives

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.01% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Maldives: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

1,671

0.00 0.00

100.00 100.00

0.00 0.00

0.00 0.00

_________________________________________________________________________________________________________

Male Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

4.16 MONGOLIA Biotechnology (US $ mln): Mongolia 1998 - 2008 Year

Mongolia

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

90

Mongolia: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

1,031 1,732 1,846 1,920 1,973 1,974 1,980

0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.03

74.25 10.84 5.83 3.12 2.03 2.03 1.90 100.00

0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.03

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Ulaanbaatar Darhan Erdenedalay Choybalsan Ulaangom Nalayh Uliastay Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

4.17 NEPAL Biotechnology (US $ mln): Nepal 1998 - 2008 Year

Nepal

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.27% 0.26% 0.26% 0.25% 0.25% 0.25% 0.24% 0.24% 0.24% 0.23% 0.23%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Nepal: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

638 814 825 869 1,022 1,074 1,316

0.06 0.04 0.04 0.03 0.02 0.02 0.01 0.22

26.43 17.10 16.65 14.85 10.57 9.00 5.40 100.00

0.07 0.04 0.04 0.04 0.03 0.02 0.01 0.25

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Kathmandu Sallyan Pyuthan Jumla Biratnagar Lalitpur Bhaktapur Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

91

4.18 NORTH KOREA Biotechnology (US $ mln): North Korea 1998 - 2008 Year

North Korea

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.15% 0.16% 0.16% 0.16% 0.16% 0.16% 0.15% 0.14% 0.14% 0.13% 0.12%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

North Korea: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

653 1,183 1,228 1,370 1,454 1,501 1,502 1,522 1,564 1,640 1,763

0.06 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.14

39.81 11.37 10.42 7.54 6.03 5.28 5.22 4.90 4.24 3.21 1.96 100.00

0.06 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.16

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Pyongyang Chongjin Nampo Sinuiju Hungnam Wonsan Kaesong Hamhung Kimchaek Haeju Sariwon Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

92

4.19 PAPUA NEW GUINEA Biotechnology (US $ mln): Papua New Guinea 1998 - 2008 Year

Papua New Guinea

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.10% 0.09% 0.09% 0.09% 0.09% 0.09% 0.09% 0.09% 0.08% 0.08% 0.08%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Papua New Guinea: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

828 1,089 1,559 1,580 1,592 1,677 1,736

0.04 0.02 0.01 0.01 0.01 0.00 0.00 0.08

45.92 24.17 7.55 6.95 6.65 4.83 3.93 100.00

0.04 0.02 0.01 0.01 0.01 0.00 0.00 0.09

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Port Moresby Lae Madang Wewak Goroka Rabaul Mount Hagen Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

93

4.20 PHILIPPINES Biotechnology (US $ mln): Philippines 1998 - 2008 Year

Philippines

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

2 2 2 2 2 2 2 2 3 3 3

2.46% 2.42% 2.38% 2.34% 2.30% 2.27% 2.24% 2.21% 2.18% 2.15% 2.12%

0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Philippines: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

57 767 1,013 1,147 1,181 1,344 1,351 1,383 1,406 1,411 1,419 1,451 1,453 1,484 1,486

1.82 0.04 0.02 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.04 2.06

88.46 2.05 1.18 0.84 0.79 0.55 0.54 0.51 0.49 0.48 0.47 0.42 0.42 0.38 0.38 2.06 100.00

2.01 0.05 0.03 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.05 2.27

0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01

_________________________________________________________________________________________________________

Manila Quezon City Davao Cebu Caloocan Makati Zamboanga Cagayan de Oro Pasig Pasay Las Pinas Bacolod Valenzuela Marikina Paranaque Others Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

94

4.21 SEYCHELLES Biotechnology (US $ mln): Seychelles 1998 - 2008 Year

Seychelles

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Seychelles: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

1,759 1,995 2,009 2,010

0.00 0.00 0.00 0.00 0.00

69.70 12.12 9.09 9.09 100.00

0.00 0.00 0.00 0.00 0.00

0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Victoria Anse Boileau Cascade Anse Royale Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

95

4.22 SINGAPORE Biotechnology (US $ mln): Singapore 1998 - 2008 Year

Singapore

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

1 1 1 1 1 1 1 1 1 1 1

0.99% 0.95% 0.90% 0.86% 0.82% 0.83% 0.84% 0.86% 0.87% 0.89% 0.90%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Singapore: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

99

0.75 0.75

100.00 100.00

0.83 0.83

0.00 0.00

_________________________________________________________________________________________________________

Singapore Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

4.23 SOUTH KOREA Biotechnology (US $ mln): South Korea 1998 - 2008 Year

South Korea

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

5 5 5 5 5 5 6 6 7 8 8

6.77% 6.49% 6.21% 5.93% 5.71% 5.74% 5.81% 5.88% 5.95% 6.01% 6.08%

0.03% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

96

South Korea: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

54 111 138 164 219 220 232 246 358 410 439 677

2.55 0.64 0.45 0.37 0.22 0.22 0.21 0.19 0.12 0.10 0.09 0.05 5.22

48.85 12.29 8.68 7.05 4.16 4.16 3.99 3.62 2.37 1.99 1.81 1.03 100.00

2.80 0.71 0.50 0.40 0.24 0.24 0.23 0.21 0.14 0.11 0.10 0.06 5.74

0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.02

_________________________________________________________________________________________________________

Seoul Pusan Inchon Taegu Taejon Kwangju Ulsan Suwon Masan Chonju Cheju Mokpo Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

4.24 SRI LANKA Biotechnology (US $ mln): Sri Lanka 1998 - 2008 Year

Sri Lanka

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 1 1 1

0.52% 0.51% 0.49% 0.48% 0.47% 0.46% 0.46% 0.46% 0.46% 0.46% 0.45%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

97

Sri Lanka: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

243 676 794 806 835 905 1,155 1,307

0.19 0.05 0.04 0.04 0.04 0.03 0.02 0.01 0.42

45.56 12.74 9.54 9.21 8.67 7.27 4.07 2.94 100.00

0.21 0.06 0.04 0.04 0.04 0.03 0.02 0.01 0.46

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Colombo Dehiwala Jaffna Moratuwa Kandy Galle Negombo Trincomalee Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

4.25 TAIWAN Biotechnology (US $ mln): Taiwan 1998 - 2008 Year

Taiwan

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

2 2 2 2 2 3 3 3 3 4 4

3.24% 3.14% 3.05% 2.96% 2.87% 2.86% 2.86% 2.86% 2.86% 2.85% 2.85%

0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

98

Taiwan: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

94 178 217 327 406 517 523 532 557 629 647 670 689 703 727

0.78 0.33 0.22 0.13 0.11 0.08 0.08 0.08 0.07 0.06 0.06 0.05 0.05 0.05 0.05 0.41 2.60

29.96 12.60 8.52 5.14 4.07 2.99 2.97 2.92 2.77 2.30 2.23 2.07 2.01 1.92 1.79 15.72 100.00

0.86 0.36 0.24 0.15 0.12 0.09 0.08 0.08 0.08 0.07 0.06 0.06 0.06 0.06 0.05 0.45 2.86

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01

_________________________________________________________________________________________________________

Taipei Kaohsuing Taichung Tainan Panchiao Hsinchu Chungho Sanchung Keelung Chungli Chiayi Taoyuan Fengshan Hsintien Yungho Others Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

4.26 THAILAND Biotechnology (US $ mln): Thailand 1998 - 2008 Year

Thailand

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

2 2 2 3 3 3 3 3 3 4 4

3.32% 3.26% 3.19% 3.13% 3.07% 3.03% 3.00% 2.97% 2.94% 2.91% 2.87%

0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

99

Thailand: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

52 435 933 1,150 1,167 1,217 1,361 1,629 1,966

2.57 0.10 0.03 0.02 0.02 0.02 0.01 0.00 0.00 2.76

93.11 3.46 1.06 0.63 0.61 0.55 0.40 0.17 0.02 100.00

2.82 0.10 0.03 0.02 0.02 0.02 0.01 0.01 0.00 3.03

0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01

_________________________________________________________________________________________________________

Bangkok Chon Buri Songkhla Nakhon Ratchasima Chiang Mai Khon Kaen Nakhon Si Thammarat Phitsanulok Hat Yai Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

4.27 VIETNAM Biotechnology (US $ mln): Vietnam 1998 - 2008 Year

Vietnam

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

1 1 1 1 1 1 1 1 1 1 2

1.27% 1.24% 1.21% 1.18% 1.15% 1.14% 1.14% 1.13% 1.13% 1.12% 1.11%

0.01% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

100

Vietnam: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

180 189 248 490 493 604 1,065

0.33 0.28 0.19 0.08 0.08 0.06 0.02 1.04

31.46 26.70 18.05 7.83 7.81 6.15 2.00 100.00

0.36 0.30 0.21 0.09 0.09 0.07 0.02 1.14

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Ho Chi Minh Can Tho Hanoi Thai Nguyen Da Nang Hue Pleyku Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

101

5 EUROPE: BIOTECHNOLOGY 5.1

EXECUTIVE SUMMARY Market Potential for Biotechnology in Europe (US $ mln): 2003

Country

Latent Demand US $ mln

% of Europe

13 10 9 8 5 4 3 2 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 2 72

17.95% 13.43% 12.61% 11.78% 6.71% 5.27% 3.62% 3.06% 2.42% 1.92% 1.88% 1.84% 1.78% 1.69% 1.47% 1.26% 1.22% 1.22% 1.15% 1.11% 1.07% 0.82% 0.78% 0.73% 0.51% 2.68% 100.00%

_________________________________________________________________________________________________________

Germany France United Kingdom Italy Spain Russia Netherlands Poland Belgium Switzerland Austria Sweden Ukraine Greece Portugal Denmark Czech Republic Romania Norway Finland Hungary Kazakhstan Ireland Belarus Slovakia Other Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

102

Market Potential for Biotechnology in Europe (US $ mln): 2003 United Kingdom

Italy

France

Other Germany

The Market for Biotechnology in Europe: 1998 - 2008 Year

US $ mln

% of Globe

59.98 61.65 63.38 65.16 67.32 71.58 76.46 81.68 87.26 93.22 99.59

0.34 0.31 0.29 0.27 0.26 0.25 0.24 0.24 0.23 0.22 0.22

_________________________________________________________________________________________________________

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

5.2

103

ALBANIA Biotechnology (US $ mln): Albania 1998 - 2008

Year

Albania

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.11% 0.10% 0.10% 0.10% 0.10% 0.10% 0.10% 0.10% 0.10% 0.11% 0.11%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Albania: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

1,028 1,478 1,480 1,488 1,525 1,548 1,660 1,668 1,765

0.02 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.07

32.42 11.33 11.19 10.90 9.76 8.90 5.88 5.74 3.87 100.00

0.03 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.10

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Tirane Durres Elbasan Shkoder Vlore Korce Berat Fier Lushnje Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

5.3

104

ANDORRA Biotechnology (US $ mln): Andorra 1998 - 2008

Year

Andorra

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Andorra: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

1,632 1,739

0.00 0.00 0.01

60.00 40.00 100.00

0.01 0.00 0.01

0.00 0.00 0.00

_________________________________________________________________________________________________________

Andorra la Vella Les Escaldes Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

5.4

AUSTRIA Biotechnology (US $ mln): Austria 1998 - 2008

Year

Austria

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

1 1 1 1 1 1 1 2 2 2 2

1.87% 1.87% 1.88% 1.88% 1.89% 1.88% 1.88% 1.87% 1.87% 1.86% 1.86%

0.01% 0.01% 0.01% 0.01% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

105

Austria: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

90 346 407 547 615 734 951 966 975 1,077 1,227 1,547

0.81 0.13 0.11 0.07 0.06 0.05 0.03 0.03 0.03 0.02 0.01 0.01 1.35

60.06 9.53 7.85 5.45 4.59 3.41 2.08 2.00 1.96 1.49 1.10 0.47 100.00

1.13 0.18 0.15 0.10 0.09 0.06 0.04 0.04 0.04 0.03 0.02 0.01 1.88

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Vienna Graz Linz Salzburg Innsbruck Klagenfurt Villach Wels Sankt Poelten Steyr Bregenz Eisenstadt Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

5.5

BELARUS Biotechnology (US $ mln): Belarus 1998 - 2008

Year

Belarus

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 1 1 1 1 1 1

0.74% 0.74% 0.74% 0.73% 0.73% 0.73% 0.74% 0.74% 0.74% 0.74% 0.74%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

106

Belarus: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

236 612 743 754 861 881 953 1,080 1,123 1,203 1,224 1,299

0.20 0.06 0.04 0.04 0.03 0.03 0.03 0.02 0.02 0.02 0.01 0.01 0.53

37.91 11.93 8.49 8.35 6.44 6.15 5.32 3.79 3.44 2.93 2.84 2.41 100.00

0.28 0.09 0.06 0.06 0.05 0.05 0.04 0.03 0.03 0.02 0.02 0.02 0.73

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Minsk Gomel Mogilyov Vitebsk Grodno Brest Bobruysk Baranovichi Borisov Orsha Pinsk Mozyr Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

5.6

BELGIUM Biotechnology (US $ mln): Belgium 1998 - 2008

Year

Belgium

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

1 1 2 2 2 2 2 2 2 2 2

2.43% 2.43% 2.42% 2.42% 2.41% 2.42% 2.42% 2.43% 2.43% 2.44% 2.44%

0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

107

Belgium: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

116 184 307 338 356 549 599 658 691 716 718 719 769

0.60 0.30 0.14 0.13 0.12 0.07 0.06 0.06 0.05 0.05 0.05 0.05 0.04 1.73

34.89 17.12 8.38 7.52 7.19 4.24 3.71 3.24 3.02 2.77 2.73 2.73 2.45 100.00

0.84 0.41 0.20 0.18 0.17 0.10 0.09 0.08 0.07 0.07 0.07 0.07 0.06 2.42

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01

_________________________________________________________________________________________________________

Brussels Antwerp Ghent Charleroi Liege Bruges Namur Mons Leuven Aalst Mechelen Kortrijk Oostende Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

5.7

BOSNIA AND HERZEGOVINA Biotechnology (US $ mln): Bosnia and Herzegovina 1998 - 2008

Year

Bosnia and Herzegovina

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.07% 0.06% 0.06% 0.06% 0.06% 0.06% 0.06% 0.06% 0.07% 0.07% 0.07%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

108

Bosnia and Herzegovina: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

1,148 1,544 1,626 1,655 1,662 1,697 1,725

0.02 0.01 0.00 0.00 0.00 0.00 0.00 0.04

39.33 14.57 10.84 9.80 9.44 8.37 7.63 100.00

0.02 0.01 0.01 0.01 0.01 0.01 0.00 0.06

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Sarajevo Banja Luca Zenica Tuzla Mostar Prijedor Doboj Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

5.8

BULGARIA Biotechnology (US $ mln): Bulgaria 1998 - 2008

Year

Bulgaria

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.46% 0.46% 0.45% 0.45% 0.45% 0.45% 0.45% 0.45% 0.46% 0.46% 0.46%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

109

Bulgaria: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

353 797 859 1,043 1,057 1,149 1,225 1,308 1,328 1,331 1,368

0.13 0.04 0.03 0.02 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.32

39.05 12.35 10.58 6.85 6.57 5.40 4.64 3.84 3.70 3.67 3.36 100.00

0.18 0.06 0.05 0.03 0.03 0.02 0.02 0.02 0.02 0.02 0.02 0.45

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Sofia Plovdiv Varna Burgas Ruse Stara Zagora Pleven Tolbukhin Sliven Shumen Pernik Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

5.9

CROATIA Biotechnology (US $ mln): Croatia 1998 - 2008

Year

Croatia

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.23% 0.23% 0.23% 0.23% 0.23% 0.23% 0.23% 0.23% 0.23% 0.23% 0.23%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

110

Croatia: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

443 1,199 1,239 1,300 1,427 1,457 1,543 1,597

0.09 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.17

56.52 9.38 8.71 7.65 5.58 5.10 3.90 3.17 100.00

0.13 0.02 0.02 0.02 0.01 0.01 0.01 0.01 0.23

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Zagreb Rijeka Split Osijek Zadar Slavonski Brod Vukovar Dubrovnik Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

5.10 CYPRUS Biotechnology (US $ mln): Cyprus 1998 - 2008 Year

Cyprus

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.09% 0.09% 0.09% 0.09% 0.09% 0.09% 0.09% 0.09% 0.09% 0.09% 0.09%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Cyprus: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

947 1,072 1,441 1,526

0.03 0.02 0.01 0.01 0.06

43.83 31.50 13.91 10.76 100.00

0.04 0.03 0.01 0.01 0.09

0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Nicosia Limassol Larnaca Famagusta Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

111

5.11 DENMARK Biotechnology (US $ mln): Denmark 1998 - 2008 Year

Denmark

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

1 1 1 1 1 1 1 1 1 1 1

1.24% 1.25% 1.26% 1.26% 1.26% 1.26% 1.26% 1.25% 1.25% 1.24% 1.24%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Denmark: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

131 432 591 650 915 1,032 1,055 1,056 1,061 1,070 1,176 1,226 1,250

0.50 0.10 0.06 0.06 0.03 0.02 0.02 0.02 0.02 0.02 0.02 0.01 0.01 0.90

55.68 10.63 7.17 6.38 3.34 2.51 2.35 2.35 2.31 2.27 1.81 1.65 1.57 100.00

0.70 0.13 0.09 0.08 0.04 0.03 0.03 0.03 0.03 0.03 0.02 0.02 0.02 1.26

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Copenhagen Aarhus Odense Aalborg Esbjerg Randers Helsingor Kolding Herning Horsens Vejle Roskilde Naestved Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

112

5.12 ESTONIA Biotechnology (US $ mln): Estonia 1998 - 2008 Year

Estonia

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.14% 0.14% 0.14% 0.14% 0.14% 0.14% 0.14% 0.14% 0.14% 0.15% 0.15%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Estonia: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

655 1,278 1,421 1,439 1,550 1,785 1,792

0.06 0.01 0.01 0.01 0.01 0.00 0.00 0.10

56.71 13.41 9.65 9.06 6.35 2.47 2.35 100.00

0.08 0.02 0.01 0.01 0.01 0.00 0.00 0.14

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Tallinn Tartu Narva Kohtla-Järve Pärnu Sillamäe Rakvere Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

113

5.13 FINLAND Biotechnology (US $ mln): Finland 1998 - 2008 Year

Finland

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

1 1 1 1 1 1 1 1 1 1 1

1.14% 1.13% 1.12% 1.11% 1.10% 1.11% 1.12% 1.13% 1.14% 1.15% 1.16%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Finland: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

208 475 484 508 545 711 733 803 807 880 930

0.24 0.08 0.08 0.08 0.07 0.05 0.05 0.04 0.04 0.03 0.03 0.79

30.33 10.54 10.36 9.99 9.31 6.10 5.80 4.93 4.87 4.07 3.70 100.00

0.34 0.12 0.11 0.11 0.10 0.07 0.06 0.05 0.05 0.05 0.04 1.11

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Helsinki Tampere Espoo Turku Vantaa Oulu Lahti Pori Kuopio Jyvaskyla Kotka Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

114

5.14 FRANCE Biotechnology (US $ mln): France 1998 - 2008 Year

France

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

8 8 8 9 9 10 10 11 12 12 13

13.31% 13.35% 13.39% 13.43% 13.45% 13.43% 13.40% 13.36% 13.33% 13.29% 13.25%

0.04% 0.04% 0.04% 0.04% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

France: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

43 127 128 153 295 344 345 400 424 436 448 479 480 505 516

6.76 0.54 0.54 0.39 0.15 0.13 0.13 0.11 0.10 0.09 0.09 0.08 0.08 0.08 0.08 0.26 9.61

70.30 5.63 5.57 4.05 1.56 1.34 1.34 1.14 1.01 0.99 0.94 0.87 0.87 0.83 0.81 2.75 100.00

9.44 0.76 0.75 0.54 0.21 0.18 0.18 0.15 0.14 0.13 0.13 0.12 0.12 0.11 0.11 0.37 13.43

0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.03

_________________________________________________________________________________________________________

Paris Marseille Lyon Lille Toulouse Nice Strasbourg Nantes Rennes Bordeaux Saint-Etienne Reims Le Havre Toulon Grenoble Others Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

115

5.15 GEORGIA Biotechnology (US $ mln): Georgia 1998 - 2008 Year

Georgia

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.20% 0.21% 0.21% 0.21% 0.21% 0.21% 0.21% 0.21% 0.21% 0.20% 0.20%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Georgia: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

442 1,139 1,329 1,402 1,437 1,689 1,783 1,829

0.09 0.02 0.01 0.01 0.01 0.00 0.00 0.00 0.15

62.35 11.63 7.87 6.73 5.99 2.52 1.63 1.29 100.00

0.13 0.02 0.02 0.01 0.01 0.01 0.00 0.00 0.21

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

T'Bilisi Kutaisi Rustavi Batumi Sukhumi Poti Tskhinvali Chiatura Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

116

5.16 GERMANY Biotechnology (US $ mln): Germany 1998 - 2008 Year

Germany

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

11 11 11 12 12 13 14 15 16 17 18

17.76% 17.82% 17.88% 17.94% 17.99% 17.95% 17.89% 17.84% 17.78% 17.73% 17.67%

0.06% 0.06% 0.05% 0.05% 0.05% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Germany: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

51 103 140 144 145 147 152 430 514

2.61 0.73 0.45 0.43 0.43 0.41 0.40 0.10 0.08 5.64

20.32 5.66 3.51 3.36 3.34 3.23 3.13 0.75 0.61 43.91

3.65 1.02 0.63 0.60 0.60 0.58 0.56 0.13 0.11 7.88

0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.02

_________________________________________________________________________________________________________

Berlin Cologne Dresden Dusseldorf Dortmund Bremen Duisburg Cottbus Dessau Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

117

5.17 GREECE Biotechnology (US $ mln): Greece 1998 - 2008 Year

Greece

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

1 1 1 1 1 1 1 1 1 2 2

1.70% 1.70% 1.69% 1.69% 1.69% 1.69% 1.69% 1.70% 1.70% 1.70% 1.70%

0.01% 0.01% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Greece: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

129 209 376 476 619 623 776 865 958 964

0.52 0.24 0.12 0.08 0.06 0.06 0.04 0.03 0.03 0.03 1.21

43.07 19.74 9.58 6.90 5.01 4.96 3.45 2.77 2.28 2.24 100.00

0.73 0.33 0.16 0.12 0.08 0.08 0.06 0.05 0.04 0.04 1.69

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Athens Thessaloniki Piraeus Patras Larissa Iraklion Volos Kavalla Canea Serrai Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

118

5.18 HUNGARY Biotechnology (US $ mln): Hungary 1998 - 2008 Year

Hungary

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

1 1 1 1 1 1 1 1 1 1 1

1.10% 1.09% 1.08% 1.07% 1.06% 1.07% 1.08% 1.09% 1.10% 1.11% 1.12%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Hungary: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

137 717 742 790 800 942 990 1,007 1,030 1,107 1,143

0.46 0.05 0.04 0.04 0.04 0.03 0.03 0.02 0.02 0.02 0.02 0.76

59.51 6.19 5.85 5.32 5.15 3.71 3.35 3.21 2.98 2.45 2.28 100.00

0.64 0.07 0.06 0.06 0.06 0.04 0.04 0.03 0.03 0.03 0.02 1.07

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Budapest Debrecen Miskolc Szeged Pécs Györ Nyiregyha Szekesfehérvar Kecskemét Szombathely Szolnok Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

119

5.19 ICELAND Biotechnology (US $ mln): Iceland 1998 - 2008 Year

Iceland

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.06% 0.06% 0.06% 0.06% 0.06% 0.06% 0.06% 0.06% 0.06% 0.06% 0.06%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Iceland: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

972 1,661 1,679 1,680 1,828 1,880 1,881 1,933 1,934 1,984

0.03 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.05

58.54 9.15 8.54 8.54 4.27 3.05 3.05 1.83 1.83 1.22 100.00

0.04 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.06

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Reykjavik Kopavogur Akureyri Hafnarfjordhur Keflavik Akranes Vestmannaeyjar Isafjorour Husavik Neskaupstaour Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

120

5.20 IRELAND Biotechnology (US $ mln): Ireland 1998 - 2008 Year

Ireland

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

1 1 1 1 1 1 1 1 1 1 1

0.86% 0.84% 0.81% 0.79% 0.77% 0.78% 0.81% 0.83% 0.86% 0.88% 0.91%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Ireland: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

150 519 852 1,059 1,116

0.41 0.08 0.03 0.02 0.02 0.56

73.10 13.81 6.11 3.73 3.25 100.00

0.57 0.11 0.05 0.03 0.03 0.78

0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Dublin Cork Limerick Galway Waterford Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

121

5.21 ITALY Biotechnology (US $ mln): Italy 1998 - 2008 Year

Italy

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

7 7 7 8 8 8 9 10 10 11 11

11.61% 11.67% 11.72% 11.78% 11.82% 11.78% 11.73% 11.68% 11.63% 11.57% 11.52%

0.04% 0.04% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.02%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Italy: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

56 77 83 95 121 123 181 182 187 192 205 233 239 249 257

2.14 1.12 0.91 0.78 0.55 0.55 0.32 0.32 0.28 0.27 0.25 0.21 0.20 0.19 0.18 0.17 8.43

25.35 13.31 10.81 9.22 6.56 6.50 3.84 3.79 3.35 3.23 2.95 2.44 2.33 2.20 2.13 2.00 100.00

2.99 1.57 1.27 1.09 0.77 0.77 0.45 0.45 0.39 0.38 0.35 0.29 0.27 0.26 0.25 0.24 11.78

0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.03

_________________________________________________________________________________________________________

Rome Milan Naples Turin Palermo Genoa Bologna Florence Catania Bari Venice Messina Verona Taranto Trieste Others Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

122

5.22 KAZAKHSTAN Biotechnology (US $ mln): Kazakhstan 1998 - 2008 Year

Kazakhstan

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

1 1 1 1 1 1 1 1 1 1 1

0.91% 0.88% 0.85% 0.82% 0.80% 0.82% 0.85% 0.88% 0.90% 0.93% 0.96%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Kazakhstan: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

374 606 791 849 856 868 890 938 977 1,000 1,027 1,044 1,066 1,174 1,192

0.12 0.06 0.04 0.03 0.03 0.03 0.03 0.03 0.03 0.02 0.02 0.02 0.02 0.02 0.02 0.06 0.59

19.81 10.78 6.90 5.86 5.81 5.69 5.39 4.86 4.44 4.23 3.93 3.72 3.51 2.79 2.69 9.57 100.00

0.16 0.09 0.06 0.05 0.05 0.05 0.04 0.04 0.04 0.03 0.03 0.03 0.03 0.02 0.02 0.08 0.82

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Almaty Karaganda Chimkent Semipalatinsk Pavlodar Ust-Kamenogorsk Dzhambul Tselinograd Aktyubinsk Petropavlovsk Kustanay Temirtau Uralsk Shevchenko Kzyl-Orda Others Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

123

5.23 LATVIA Biotechnology (US $ mln): Latvia 1998 - 2008 Year

Latvia

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.17% 0.17% 0.16% 0.16% 0.16% 0.16% 0.16% 0.17% 0.17% 0.17% 0.17%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Latvia: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

528 1,372 1,420 1,552 1,585 1,663 1,712

0.08 0.01 0.01 0.01 0.01 0.00 0.00 0.12

65.78 9.18 8.25 5.38 4.73 3.59 3.08 100.00

0.11 0.01 0.01 0.01 0.01 0.01 0.01 0.16

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Riga Daugavpils Liepaja Jelgava Jurmala Ventspils Rezekne Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

124

5.24 LIECHTENSTEIN Biotechnology (US $ mln): Liechtenstein 1998 - 2008 Year

Liechtenstein

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Liechtenstein: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

1,918 1,919 1,943 1,981 1,982 1,983 2,005

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

20.00 20.00 16.00 12.00 12.00 12.00 8.00 100.00

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Schaan Vaduz Balzers Mauren Eschen Triesen Triesenberg Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

125

5.25 LITHUANIA Biotechnology (US $ mln): Lithuania 1998 - 2008 Year

Lithuania

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.24% 0.24% 0.24% 0.24% 0.25% 0.24% 0.24% 0.24% 0.24% 0.24% 0.24%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Lithuania: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

553 713 1,024 1,169 1,233

0.07 0.05 0.02 0.02 0.01 0.18

41.37 27.56 13.24 9.48 8.34 100.00

0.10 0.07 0.03 0.02 0.02 0.24

0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Vilnius Kaunas Klaipeda Siauliai Panevezys Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

126

5.26 LUXEMBOURG Biotechnology (US $ mln): Luxembourg 1998 - 2008 Year

Luxembourg

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.15% 0.15% 0.15% 0.15% 0.15% 0.15% 0.15% 0.15% 0.15% 0.16% 0.16%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Luxembourg: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

681 1,171 1,355 1,417 1,469 1,470

0.05 0.02 0.01 0.01 0.01 0.01 0.11

49.68 15.48 10.32 9.03 7.74 7.74 100.00

0.07 0.02 0.02 0.01 0.01 0.01 0.15

0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Luxembourg Esch Differdange Dudelange Remich Petange Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

127

5.27 MALTA Biotechnology (US $ mln): Malta 1998 - 2008 Year

Malta

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.05% 0.05% 0.05% 0.05% 0.05% 0.05% 0.05% 0.05% 0.05% 0.05% 0.05%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Malta: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

1,352 1,377 1,487 1,610 1,764

0.01 0.01 0.01 0.01 0.00 0.04

29.85 28.36 20.90 13.43 7.46 100.00

0.02 0.01 0.01 0.01 0.00 0.05

0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Birkirkara Qormi Sliema Valletta Victoria Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

128

5.28 MOLDOVA Biotechnology (US $ mln): Moldova 1998 - 2008 Year

Moldova

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.09% 0.10% 0.10% 0.10% 0.10% 0.10% 0.10% 0.10% 0.10% 0.09% 0.09%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Moldova: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

763 1,332 1,396 1,463

0.04 0.01 0.01 0.01 0.07

58.54 16.02 14.00 11.44 100.00

0.06 0.02 0.01 0.01 0.10

0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Chisinau Tiraspol Beltsy Bendery Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

129

5.29 MONACO Biotechnology (US $ mln): Monaco 1998 - 2008 Year

Monaco

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Monaco: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

1,615 1,946

0.00 0.00 0.01

86.67 13.33 100.00

0.01 0.00 0.01

0.00 0.00 0.00

_________________________________________________________________________________________________________

Monte Carlo Monaco Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

5.30 NETHERLANDS Biotechnology (US $ mln): Netherlands 1998 - 2008 Year

Netherlands

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

2 2 2 2 2 3 3 3 3 3 4

3.64% 3.63% 3.62% 3.62% 3.61% 3.62% 3.62% 3.63% 3.64% 3.64% 3.65%

0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

130

Netherlands: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

114 141 155 193 240 259 288 385 481 594 611 872

0.61 0.44 0.39 0.27 0.19 0.17 0.15 0.12 0.08 0.06 0.06 0.03 2.59

23.59 17.08 14.93 10.37 7.50 6.75 5.94 4.44 3.20 2.49 2.42 1.27 100.00

0.85 0.62 0.54 0.38 0.27 0.24 0.21 0.16 0.12 0.09 0.09 0.05 3.62

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01

_________________________________________________________________________________________________________

Rotterdam Amsterdam - Haarlem Eindhoven - Tilberg Gelderland Utrecht Limburg Overijssel Groningen Friesland Zeeland Drenthe Flevoland Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

5.31 NORWAY Biotechnology (US $ mln): Norway 1998 - 2008 Year

Norway

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

1 1 1 1 1 1 1 1 1 1 1

1.13% 1.14% 1.14% 1.15% 1.15% 1.15% 1.14% 1.14% 1.13% 1.13% 1.12%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

131

Norway: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

175 291 420 566 737 822 842 981 995

0.33 0.15 0.10 0.07 0.05 0.04 0.04 0.03 0.03 0.82

40.14 18.57 12.06 8.54 5.55 4.58 4.31 3.17 3.08 100.00

0.46 0.21 0.14 0.10 0.06 0.05 0.05 0.04 0.04 1.15

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Oslo Bergen Trondheim Stavanger Kristiansand Drammen Tromso Alesund Bodo Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

5.32 POLAND Biotechnology (US $ mln): Poland 1998 - 2008 Year

Poland

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

2 2 2 2 2 2 2 3 3 3 3

3.12% 3.10% 3.08% 3.06% 3.05% 3.06% 3.08% 3.10% 3.11% 3.13% 3.14%

0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

132

Poland: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

124 188 207 231 242 289 339 360 366 402 470

0.55 0.28 0.24 0.21 0.19 0.15 0.13 0.12 0.12 0.11 0.09 2.19

24.99 12.64 11.14 9.57 8.76 7.01 5.92 5.58 5.52 4.98 3.89 100.00

0.77 0.39 0.34 0.29 0.27 0.21 0.18 0.17 0.17 0.15 0.12 3.06

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01

_________________________________________________________________________________________________________

Warsaw Lodz Krakow Wroclaw Poznan Gdansk Szczecin Bydgoszcz Katowice Lublin Sosnowiec Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

5.33 PORTUGAL Biotechnology (US $ mln): Portugal 1998 - 2008 Year

Portugal

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

1 1 1 1 1 1 1 1 1 1 1

1.45% 1.46% 1.46% 1.47% 1.48% 1.47% 1.47% 1.46% 1.45% 1.45% 1.44%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

133

Portugal: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

130 221 628 709 724 801 808 886 960 971

0.52 0.22 0.06 0.05 0.05 0.04 0.04 0.03 0.03 0.03 1.05

49.14 20.54 5.68 4.62 4.44 3.73 3.67 3.02 2.61 2.55 100.00

0.72 0.30 0.08 0.07 0.07 0.05 0.05 0.04 0.04 0.04 1.47

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Lisbon Oporto Amadora Setubal Coimbra Braga Vila Nova de Gaia Barreiro Funchal Almada Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

5.34 ROMANIA Biotechnology (US $ mln): Romania 1998 - 2008 Year

Romania

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

1 1 1 1 1 1 1 1 1 1 1

1.20% 1.20% 1.21% 1.22% 1.23% 1.22% 1.22% 1.21% 1.20% 1.19% 1.18%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

134

Romania: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

166 609 641 644 656 662 683 701 766 771 812

0.36 0.06 0.06 0.06 0.06 0.06 0.05 0.05 0.04 0.04 0.04 0.88

40.80 7.20 6.72 6.66 6.42 6.36 6.05 5.76 4.84 4.82 4.39 100.00

0.50 0.09 0.08 0.08 0.08 0.08 0.07 0.07 0.06 0.06 0.05 1.22

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Bucharest Brasov Constanta Timisoara Iasi Cluj-Napoca Galati Craiova Braila Ploiesti Oradea Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

5.35 RUSSIA Biotechnology (US $ mln): Russia 1998 - 2008 Year

Russia

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

3 3 3 3 4 4 4 4 5 5 6

5.50% 5.42% 5.35% 5.28% 5.22% 5.27% 5.34% 5.40% 5.47% 5.54% 5.61%

0.02% 0.02% 0.02% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

135

Russia: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

74 112 252 253 261 276 303 305 318 342 352 380 387 485 507

1.14 0.64 0.18 0.18 0.17 0.16 0.15 0.15 0.14 0.13 0.13 0.12 0.11 0.08 0.08 0.22 3.77

30.16 16.88 4.84 4.83 4.60 4.23 3.86 3.84 3.68 3.43 3.36 3.07 3.04 2.18 2.11 5.90 100.00

1.59 0.89 0.26 0.25 0.24 0.22 0.20 0.20 0.19 0.18 0.18 0.16 0.16 0.11 0.11 0.31 5.27

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01

_________________________________________________________________________________________________________

Moscow Saint Petersburg Nizhni Novgorod Novosibirsk Yekaterinburg Kuybyshev Omsk Chelyabinsk Kazan Rostov-on-Don Volgograd Krasnoyark Saratov Vladivostok Irkutsk Others Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

5.36 SAN MARINO Biotechnology (US $ mln): San Marino 1998 - 2008 Year

San Marino

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

136

San Marino: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

1,695 1,812

0.00 0.00 0.01

63.64 36.36 100.00

0.01 0.00 0.01

0.00 0.00 0.00

_________________________________________________________________________________________________________

Serravalle San Marino Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

5.37 SLOVAKIA Biotechnology (US $ mln): Slovakia 1998 - 2008 Year

Slovakia

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.50% 0.50% 0.51% 0.51% 0.51% 0.51% 0.51% 0.50% 0.50% 0.50% 0.49%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Slovakia: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

334 725 772 837 1,001 1,102 1,340 1,345 1,348 1,363 1,390 1,391

0.13 0.05 0.04 0.04 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.37

35.87 12.79 11.54 9.82 6.81 5.21 3.15 3.12 3.06 2.97 2.83 2.83 100.00

0.18 0.07 0.06 0.05 0.03 0.03 0.02 0.02 0.02 0.02 0.01 0.01 0.51

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Prague Bratislava Brno Ostrava Kosice Plzen Olomouc Usti nad Labem Liberec Hradec Kralove Ceske Budejovice Pardubice Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

137

5.38 SLOVENIA Biotechnology (US $ mln): Slovenia 1998 - 2008 Year

Slovenia

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.22% 0.22% 0.21% 0.21% 0.21% 0.21% 0.21% 0.22% 0.22% 0.22% 0.22%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Slovenia: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

551 748 1,405 1,475 1,482 1,627 1,628

0.07 0.04 0.01 0.01 0.01 0.00 0.00 0.15

47.66 29.06 6.56 5.31 5.16 3.13 3.13 100.00

0.10 0.06 0.01 0.01 0.01 0.01 0.01 0.21

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Ljubljana Maribor Koper Kranj Celje Jesenice Trbovlje Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

138

5.39 SPAIN Biotechnology (US $ mln): Spain 1998 - 2008 Year

Spain

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

4 4 4 4 5 5 5 6 6 6 7

6.75% 6.74% 6.73% 6.71% 6.70% 6.71% 6.72% 6.74% 6.75% 6.76% 6.77%

0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.01%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Spain: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

65 98 179 185 200 204 265 275 299 321 322 329 357 384 388

1.38 0.76 0.33 0.29 0.26 0.25 0.17 0.16 0.15 0.14 0.14 0.13 0.12 0.12 0.11 0.30 4.81

28.79 15.82 6.80 6.08 5.34 5.25 3.55 3.32 3.05 2.85 2.83 2.77 2.58 2.40 2.39 6.19 100.00

1.93 1.06 0.46 0.41 0.36 0.35 0.24 0.22 0.21 0.19 0.19 0.19 0.17 0.16 0.16 0.42 6.71

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.02

_________________________________________________________________________________________________________

Madrid Barcelona Valencia Sevilla Zaragoza Malaga Bilbao Las Palmas Valladolid Palma Murcia Cordoba Hospitalet Alicante Granada Others Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

139

5.40 SWEDEN Biotechnology (US $ mln): Sweden 1998 - 2008 Year

Sweden

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

1 1 1 1 1 1 1 2 2 2 2

1.86% 1.85% 1.84% 1.84% 1.83% 1.84% 1.84% 1.85% 1.85% 1.86% 1.87%

0.01% 0.01% 0.01% 0.01% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Sweden: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

173 224 379 494 627 632 633 634 663 679 700 729 749 753 830

0.33 0.22 0.12 0.08 0.06 0.06 0.06 0.06 0.05 0.05 0.05 0.05 0.04 0.04 0.04 1.32

25.41 16.37 8.81 6.15 4.56 4.52 4.52 4.52 4.18 4.06 3.84 3.53 3.38 3.34 2.81 100.00

0.47 0.30 0.16 0.11 0.08 0.08 0.08 0.08 0.08 0.07 0.07 0.06 0.06 0.06 0.05 1.84

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Stockholm Göteborg Malmö Uppsala Örebro Västeras Linköping Norrköping Jönköping Helsingborg Boras Sundsvall Umea Gävle Skelleftea Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

140

5.41 SWITZERLAND Biotechnology (US $ mln): Switzerland 1998 - 2008 Year

Switzerland

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

1 1 1 1 1 1 1 2 2 2 2

1.90% 1.91% 1.91% 1.92% 1.92% 1.92% 1.91% 1.91% 1.90% 1.90% 1.89%

0.01% 0.01% 0.01% 0.01% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Switzerland: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

161 251 260 301 328 451 520 605 669 802 815

0.37 0.18 0.17 0.15 0.13 0.09 0.08 0.06 0.05 0.04 0.04 1.37

27.10 13.44 12.66 10.66 9.73 6.56 5.64 4.63 3.94 2.86 2.78 100.00

0.52 0.26 0.24 0.20 0.19 0.13 0.11 0.09 0.08 0.05 0.05 1.92

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Zürich Basel Geneva Bern Lausanne Winterthur Saint Gallen Luzern Biel Thun Koniz Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

141

5.42 UKRAINE Biotechnology (US $ mln): Ukraine 1998 - 2008 Year

Ukraine

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

1 1 1 1 1 1 1 1 2 2 2

1.85% 1.83% 1.80% 1.78% 1.77% 1.78% 1.80% 1.82% 1.84% 1.86% 1.88%

0.01% 0.01% 0.01% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Ukraine: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

211 302 405 417 418 499 558 590 722 736 739 804 860 879 882

0.24 0.15 0.11 0.10 0.10 0.08 0.07 0.06 0.05 0.05 0.05 0.04 0.03 0.03 0.03 0.09 1.27

18.44 11.48 8.40 7.95 7.91 6.30 5.63 5.08 3.68 3.58 3.54 3.06 2.67 2.54 2.53 7.20 100.00

0.33 0.20 0.15 0.14 0.14 0.11 0.10 0.09 0.07 0.06 0.06 0.05 0.05 0.05 0.05 0.13 1.78

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Kiev Kharkiv Dnipropetrovsk Odessa Donetsk Zaporozhye Lviv Krivoy Rog Mariupol (Zhdanov) Nikolayev Lugansk Makeyevka Vinnitsa Sevastopol Kherson Others Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

142

5.43 UNITED KINGDOM Biotechnology (US $ mln): United Kingdom 1998 - 2008 Year

United Kingdom

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

7 8 8 8 9 9 10 10 11 12 12

12.48% 12.52% 12.56% 12.60% 12.63% 12.61% 12.57% 12.53% 12.49% 12.45% 12.41%

0.04% 0.04% 0.04% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

United Kingdom: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

47 84 86 101 102 133 146 156 159 167 171 183

3.16 0.88 0.87 0.73 0.73 0.47 0.42 0.38 0.38 0.36 0.34 0.30 9.02

35.03 9.73 9.67 8.09 8.09 5.21 4.65 4.25 4.22 3.95 3.73 3.36 100.00

4.42 1.23 1.22 1.02 1.02 0.66 0.59 0.54 0.53 0.50 0.47 0.42 12.61

0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.03

_________________________________________________________________________________________________________

London Birmingham Manchester Leeds Bradford Liverpool Sheffield Bristol Coventry Nottingham Leicester Hull Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

143

6 LATIN AMERICA: BIOTECHNOLOGY 6.1

EXECUTIVE SUMMARY Market Potential for Biotechnology in Latin America (US $ mln): 2003

Country

Latent Demand US $ mln

% of Latin America

8 6 3 2 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 23

32.68% 26.83% 13.54% 7.19% 4.45% 4.21% 3.55% 1.33% 1.06% 0.87% 0.75% 0.72% 0.69% 0.60% 0.49% 0.48% 0.38% 0.10% 0.04% 0.03% 0.02% 0.00% 100.00%

_________________________________________________________________________________________________________

Brazil Mexico Argentina Colombia Chile Venezuela Peru Guatemala Ecuador Uruguay Paraguay Costa Rica El Salvador Bolivia Honduras Panama Nicaragua Guyana Suriname French Guiana Belize Falkland Islands Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

144

Market Potential for Biotechnology in Latin America (US $ mln): 2003 Argentina Mexico

Colombia

Other Brazil

The Market for Biotechnology in Latin America: 1998 - 2008 Year

US $ mln

% of Globe

19.53 20.01 20.50 21.01 21.66 23.08 24.72 26.49 28.38 30.42 32.60

0.11 0.10 0.09 0.09 0.08 0.08 0.08 0.08 0.07 0.07 0.07

_________________________________________________________________________________________________________

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

6.2

145

ARGENTINA Biotechnology (US $ mln): Argentina 1998 - 2008

Year

Argentina

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

3 3 3 3 3 3 3 3 4 4 4

12.81% 13.05% 13.29% 13.53% 13.71% 13.54% 13.32% 13.11% 12.89% 12.68% 12.47%

0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Argentina: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

157 158 160 238 278 320 347 368 370 372 391 454 542 550 561

0.38 0.38 0.38 0.20 0.16 0.14 0.13 0.12 0.12 0.12 0.11 0.09 0.07 0.07 0.07 0.58 3.13

12.21 12.20 12.15 6.30 5.07 4.40 4.11 3.84 3.82 3.73 3.60 2.87 2.39 2.35 2.29 18.67 100.00

1.65 1.65 1.65 0.85 0.69 0.60 0.56 0.52 0.52 0.51 0.49 0.39 0.32 0.32 0.31 2.53 13.54

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01

_________________________________________________________________________________________________________

Buenos Aires Santa Fe Cordoba Mendoza Tucumán Entre Rios Salta Rosario Misiones Chaco Corrientes Santiago del Estero Río Negro Jujuy San Juan Others Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

6.3

146

BELIZE Biotechnology (US $ mln): Belize 1998 - 2008

Year

Belize

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Belize: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

1,737 1,968 1,969 1,987 2,028

0.00 0.00 0.00 0.00 0.00 0.01

60.00 12.50 12.50 10.00 5.00 100.00

0.01 0.00 0.00 0.00 0.00 0.02

0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Belize City Corozal Orange Walk Dangriga Belmopan Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

6.4

147

BOLIVIA Biotechnology (US $ mln): Bolivia 1998 - 2008

Year

Bolivia

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.58% 0.59% 0.59% 0.60% 0.60% 0.60% 0.59% 0.59% 0.58% 0.58% 0.57%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Bolivia: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

651 854 1,063 1,371 1,555 1,598 1,710

0.06 0.03 0.02 0.01 0.01 0.01 0.00 0.14

41.65 24.74 15.01 7.72 4.49 3.78 2.60 100.00

0.25 0.15 0.09 0.05 0.03 0.02 0.02 0.60

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

La Paz Santa Cruz Cochabamba Oruro Potosi Sucre Tarija Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

6.5

148

BRAZIL Biotechnology (US $ mln): Brazil 1998 - 2008

Year

Brazil

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

6 7 7 7 7 8 8 9 9 10 11

32.63% 32.65% 32.67% 32.68% 32.68% 32.68% 32.67% 32.65% 32.64% 32.62% 32.59%

0.04% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.02% 0.02% 0.02% 0.02%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Brazil: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

79 120 216 229 247 250 315 326 331 335 396 422 453 472 482

1.01 0.57 0.22 0.21 0.19 0.19 0.14 0.13 0.13 0.13 0.11 0.10 0.09 0.09 0.08 4.15 7.54

13.35 7.53 2.95 2.80 2.51 2.47 1.85 1.78 1.76 1.74 1.46 1.30 1.19 1.13 1.10 55.09 100.00

4.36 2.46 0.96 0.91 0.82 0.81 0.60 0.58 0.58 0.57 0.48 0.42 0.39 0.37 0.36 18.00 32.68

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.03

_________________________________________________________________________________________________________

Sao Paulo Rio de Janeiro Salvador Belo Horizonte Fortaleza Brasilia Curitiba Recife Belem Pórto Alegre Manaus Goiânia Campinas Guarulhos Sao Gonçalo Others Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

6.6

149

CHILE Biotechnology (US $ mln): Chile 1998 - 2008

Year

Chile

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

1 1 1 1 1 1 1 1 1 1 1

4.54% 4.51% 4.48% 4.46% 4.44% 4.45% 4.48% 4.51% 4.53% 4.56% 4.58%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Chile: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

107 697 728 760 817 826 844 937 976 985 1,081 1,146

0.66 0.05 0.05 0.04 0.04 0.04 0.03 0.03 0.03 0.03 0.02 0.02 1.03

64.14 4.92 4.53 4.21 3.70 3.62 3.40 2.79 2.55 2.52 1.93 1.69 100.00

2.86 0.22 0.20 0.19 0.16 0.16 0.15 0.12 0.11 0.11 0.09 0.08 4.45

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Santiago Concepcion Viña del Mar Valparaiso Talcahuano Temuco Antofagasta Rancagua Talca Arica Puerto Montt Punta Arenas Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

6.7

150

COLOMBIA Biotechnology (US $ mln): Colombia 1998 - 2008

Year

Colombia

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

1 1 1 2 2 2 2 2 2 2 2

7.04% 7.09% 7.14% 7.19% 7.22% 7.19% 7.15% 7.10% 7.06% 7.02% 6.97%

0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Colombia: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

100 218 226 465 468 741 775 820 873 888 1,012 1,109 1,177 1,206 1,240

0.75 0.22 0.21 0.09 0.09 0.05 0.04 0.04 0.03 0.03 0.02 0.02 0.02 0.02 0.01 0.03 1.66

45.36 13.10 12.81 5.21 5.16 2.71 2.53 2.28 1.99 1.91 1.46 1.12 0.99 0.92 0.87 1.58 100.00

3.26 0.94 0.92 0.37 0.37 0.20 0.18 0.16 0.14 0.14 0.11 0.08 0.07 0.07 0.06 0.11 7.19

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01

_________________________________________________________________________________________________________

Bogota Cali Medell¡n Barranquilla Cartagena Bucaramanga Cucuta Pereira Manizales Ibague Armenia Santa Marta Neiva Pasto Monteria Others Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

6.8

151

COSTA RICA Biotechnology (US $ mln): Costa Rica 1998 - 2008

Year

Costa Rica

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.70% 0.71% 0.71% 0.72% 0.72% 0.72% 0.71% 0.71% 0.71% 0.70% 0.70%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Costa Rica: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

626 892 1,049 1,110 1,269 1,270 1,516

0.06 0.03 0.02 0.02 0.01 0.01 0.01 0.17

36.14 19.04 13.08 11.14 8.16 8.16 4.27 100.00

0.26 0.14 0.09 0.08 0.06 0.06 0.03 0.72

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

San Jose Alajuela Cartago Puntarenas Heredia Limon Liberia Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

6.9

152

ECUADOR Biotechnology (US $ mln): Ecuador 1998 - 2008

Year

Ecuador

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

1.00% 1.02% 1.04% 1.06% 1.07% 1.06% 1.04% 1.02% 1.01% 0.99% 0.97%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Ecuador: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

412 537 1,276 1,413 1,422 1,428 1,472 1,481 1,520

0.10 0.08 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.24

42.53 30.89 5.46 3.98 3.90 3.75 3.35 3.25 2.88 100.00

0.45 0.33 0.06 0.04 0.04 0.04 0.04 0.03 0.03 1.06

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Guayaquil Quito Cuenca Machala Portoviejo Riobamba Ambato Manta Esmeraldas Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

153

6.10 EL SALVADOR Biotechnology (US $ mln): El Salvador 1998 - 2008 Year

El Salvador

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.67% 0.68% 0.68% 0.69% 0.69% 0.69% 0.68% 0.68% 0.67% 0.67% 0.66%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

El Salvador: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

455 968 1,163 1,401 1,429 1,562

0.09 0.03 0.02 0.01 0.01 0.01 0.16

56.44 16.93 10.67 6.38 5.77 3.80 100.00

0.39 0.12 0.07 0.04 0.04 0.03 0.69

0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

San Salvador Santa Ana San Miguel Nueva San Salvador Sonsonate Cojutepeque Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

154

6.11 FALKLAND ISLANDS Biotechnology (US $ mln): Falkland Islands 1998 - 2008 Year

Falkland Islands

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Falkland Islands: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

2,019

0.00 0.00

100.00 100.00

0.00 0.00

0.00 0.00

_________________________________________________________________________________________________________

Stanley Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

6.12 FRENCH GUIANA Biotechnology (US $ mln): French Guiana 1998 - 2008 Year

French Guiana

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

155

French Guiana: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

1,652 1,944 1,970 1,985 2,035

0.00 0.00 0.00 0.00 0.00 0.01

66.67 11.67 10.00 8.33 3.33 100.00

0.02 0.00 0.00 0.00 0.00 0.03

0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Cayenne Kourou Remire Saint Laurent Sinnamary Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

6.13 GUATEMALA Biotechnology (US $ mln): Guatemala 1998 - 2008 Year

Guatemala

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

1.30% 1.31% 1.32% 1.33% 1.33% 1.33% 1.32% 1.31% 1.30% 1.30% 1.29%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Guatemala: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

212 1,172 1,197 1,394 1,403 1,425 1,426 1,464

0.23 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.31

74.02 5.39 5.11 3.36 3.29 3.08 3.01 2.73 100.00

0.98 0.07 0.07 0.04 0.04 0.04 0.04 0.04 1.33

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Guatemala City Escuintla Quezaltenango Puerto Barrios Retalhuleu Coban Chiquimula Mazatenango Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

156

6.14 GUYANA Biotechnology (US $ mln): Guyana 1998 - 2008 Year

Guyana

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.10% 0.10% 0.10% 0.10% 0.10% 0.10% 0.10% 0.10% 0.10% 0.10% 0.09%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Guyana: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

1,162 1,774 1,851 1,922 2,000

0.02 0.00 0.00 0.00 0.00 0.02

75.19 11.28 7.52 4.14 1.88 100.00

0.07 0.01 0.01 0.00 0.00 0.10

0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Georgetown Linden New Amsterdam Corriverton Mahaicony Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

157

6.15 HONDURAS Biotechnology (US $ mln): Honduras 1998 - 2008 Year

Honduras

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.50% 0.50% 0.50% 0.49% 0.49% 0.49% 0.50% 0.50% 0.50% 0.50% 0.50%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Honduras: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

696 858 1,596 1,602 1,621 1,728 1,773 1,804 1,818 1,853 1,859

0.05 0.03 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.11

44.79 29.98 4.61 4.54 4.26 2.94 2.24 1.96 1.82 1.47 1.40 100.00

0.22 0.15 0.02 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.49

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Tegucigalpa San Pedro Sula La Ceiba Choluteca El Progreso Puerto Cortes Comayagua Tela Siguatepeque Santa Rosa de Copan Danli Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

158

6.16 MEXICO Biotechnology (US $ mln): Mexico 1998 - 2008 Year

Mexico

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

5 6 6 6 6 6 7 7 8 9 9

28.03% 27.63% 27.24% 26.85% 26.56% 26.83% 27.18% 27.54% 27.89% 28.26% 28.62%

0.03% 0.03% 0.03% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Mexico: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

58 170 201 203 214 223 230 234 308 309 312 337 341 367 369

1.76 0.34 0.26 0.25 0.23 0.22 0.21 0.21 0.14 0.14 0.14 0.13 0.13 0.12 0.12 1.79 6.19

28.42 5.47 4.13 4.10 3.64 3.49 3.39 3.32 2.33 2.33 2.30 2.10 2.10 1.95 1.94 28.99 100.00

7.62 1.47 1.11 1.10 0.98 0.94 0.91 0.89 0.63 0.63 0.62 0.56 0.56 0.52 0.52 7.78 26.83

0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.02

_________________________________________________________________________________________________________

Mexico City Guadalajara Nezahualcoyotl Puebla Monterrey Leon Ciudad Juarez Tijuana Culiacan Mexicali Acapulco Chihuahua S. Luis Potosi Aguascalientes Morelia Others Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

159

6.17 NICARAGUA Biotechnology (US $ mln): Nicaragua 1998 - 2008 Year

Nicaragua

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.38% 0.38% 0.38% 0.38% 0.38% 0.38% 0.38% 0.38% 0.38% 0.39% 0.39%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Nicaragua: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

781 1,085 1,557 1,589 1,639 1,665 1,800 1,817 1,836

0.04 0.02 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.09

47.30 22.54 7.00 6.17 5.20 4.72 2.57 2.36 2.15 100.00

0.18 0.09 0.03 0.02 0.02 0.02 0.01 0.01 0.01 0.38

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Managua Rosita Leon Granada Masaya Chinandega Matagalpa San Carlos Esteli Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

160

6.18 PANAMA Biotechnology (US $ mln): Panama 1998 - 2008 Year

Panama

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.46% 0.47% 0.47% 0.48% 0.48% 0.48% 0.47% 0.47% 0.46% 0.46% 0.46%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Panama: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

572 1,336 1,462 1,492 1,612 1,617 1,849 1,858

0.07 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.11

62.90 10.55 7.64 6.94 4.51 4.46 1.54 1.46 100.00

0.30 0.05 0.04 0.03 0.02 0.02 0.01 0.01 0.48

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Panama Colon David La Chorrera Penonome Santiago Bocas del Toro Tocumen Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

161

6.19 PARAGUAY Biotechnology (US $ mln): Paraguay 1998 - 2008 Year

Paraguay

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.71% 0.72% 0.73% 0.75% 0.75% 0.75% 0.73% 0.72% 0.71% 0.70% 0.69%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Paraguay: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

413 1,198 1,346 1,347 1,400 1,651 1,699 1,700 1,741 1,742 1,757

0.10 0.02 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.17

59.85 9.03 6.57 6.57 5.91 2.55 2.13 2.13 1.81 1.81 1.64 100.00

0.45 0.07 0.05 0.05 0.04 0.02 0.02 0.02 0.01 0.01 0.01 0.75

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Asuncion Puerto Stroessner Pedro Juan Caballero San Lorenzo Fernando de la Mora Encarnacion Concepción Pilar Villarrica Coronel Oviedo Caaguazu Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

162

6.20 PERU Biotechnology (US $ mln): Peru 1998 - 2008 Year

Peru

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

1 1 1 1 1 1 1 1 1 1 1

3.51% 3.52% 3.53% 3.55% 3.55% 3.55% 3.54% 3.52% 3.51% 3.50% 3.49%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Peru: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

135 639 659 706 799 925 955 994 1,004 1,084 1,234 1,251

0.46 0.06 0.06 0.05 0.04 0.03 0.03 0.03 0.02 0.02 0.01 0.01 0.82

56.10 7.21 6.82 5.98 4.81 3.62 3.40 3.11 3.02 2.42 1.78 1.72 100.00

1.99 0.26 0.24 0.21 0.17 0.13 0.12 0.11 0.11 0.09 0.06 0.06 3.55

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Lima Arequipa Callao Trujillo Chiclayo Piura Chimbote Cuzco Iquitos Huancayo Sullana Pucallpa Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

163

6.21 SURINAME Biotechnology (US $ mln): Suriname 1998 - 2008 Year

Suriname

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Suriname: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

1,461 1,972 2,022 2,051 2,059

0.01 0.00 0.00 0.00 0.00 0.01

87.39 6.72 3.36 1.68 0.84 100.00

0.04 0.00 0.00 0.00 0.00 0.04

0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Paramaribo Nieuw Nickerie Marienburg Moengo Totness Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

164

6.22 URUGUAY Biotechnology (US $ mln): Uruguay 1998 - 2008 Year

Uruguay

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.80% 0.82% 0.85% 0.87% 0.89% 0.87% 0.85% 0.83% 0.81% 0.79% 0.77%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Uruguay: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

294 1,412 1,434 1,508 1,535 1,607 1,624 1,646 1,657

0.15 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.20

74.51 4.84 4.48 3.64 3.34 2.51 2.39 2.21 2.09 100.00

0.65 0.04 0.04 0.03 0.03 0.02 0.02 0.02 0.02 0.87

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Montevideo Salto Paysandu Las Piedras Rivera Melo Tacuarembo Mercedes Minas Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

165

6.23 VENEZUELA Biotechnology (US $ mln): Venezuela 1998 - 2008 Year

Venezuela

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

1 1 1 1 1 1 1 1 1 1 1

4.14% 4.16% 4.18% 4.21% 4.22% 4.21% 4.19% 4.17% 4.14% 4.12% 4.10%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Venezuela: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

197 421 461 580 664 809 821 989 1,011 1,075 1,083 1,092 1,097 1,106 1,137

0.26 0.10 0.09 0.07 0.05 0.04 0.04 0.03 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.16 0.97

26.70 10.15 9.01 6.80 5.65 3.97 3.89 2.65 2.51 2.08 2.04 1.99 1.98 1.95 1.81 16.83 100.00

1.12 0.43 0.38 0.29 0.24 0.17 0.16 0.11 0.11 0.09 0.09 0.08 0.08 0.08 0.08 0.71 4.21

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Caracas Maracaibo Valencia Maracay Barquisimeto Petare Ciudad Guayana San Cristobal La Guaira Baruta Ciudad Bolivar Maturin Merida Cumana Barcelona Others Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

166

7 NORTH AMERICA & THE CARIBBEAN: BIOTECHNOLOGY 7.1

EXECUTIVE SUMMARY

Market Potential for Biotechnology in North America & the Caribbean (US $ mln): 2003 Country

Latent Demand US $ mln % of North America & the Caribbean

_________________________________________________________________________________________________________

United States Canada Dominican Republic Puerto Rico Cuba Haiti Trinidad and Tobago Jamaica Bahamas Martinique Barbados Guadeloupe Netherlands Antilles Bermuda Aruba Virgin Islands, US Greenland Cayman Islands St. Lucia Antigua and Barbuda Grenada St. Vincent and the Grenadines British Virgin Islands Dominica St. Kitts and Nevis Other Total

28,484 5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 28,490

99.98% 0.02% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 100.00%

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

167

Market Potential for Biotechnology in North America & the Caribbean (US $ mln): 2003

United States Other Canada Dominican Republic Puerto Rico

The Market for Biotechnology in North America & the Caribbean: 1998 - 2008 Year

US $ mln

% of Globe

17,691.42 19,460.15 21,405.76 23,545.91 25,900.10 28,489.91 31,338.72 34,472.40 37,919.43 41,711.16 45,882.04

99.04 99.10 99.15 99.20 99.24 99.26 99.28 99.30 99.31 99.33 99.34

_________________________________________________________________________________________________________

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

7.2

168

ANTIGUA AND BARBUDA Biotechnology (US $ mln): Antigua and Barbuda 1998 - 2008

Year

Antigua and Barbuda

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Antigua and Barbuda: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

1,719 2,057

0.00 0.00 0.00

97.30 2.70 100.00

0.00 0.00 0.00

0.00 0.00 0.00

_________________________________________________________________________________________________________

Saint John's Codrington Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

7.3

ARUBA Biotechnology (US $ mln): Aruba 1998 - 2008

Year

Aruba

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

169

Aruba: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

1,513 1,558

0.01 0.01 0.01

54.05 45.95 100.00

0.00 0.00 0.00

0.00 0.00 0.00

_________________________________________________________________________________________________________

Oranjestad Sint Nicolaas Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

7.4

BAHAMAS Biotechnology (US $ mln): Bahamas 1998 - 2008

Year

Bahamas

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Bahamas: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

993 1,642

0.03 0.00 0.03

84.91 15.09 100.00

0.00 0.00 0.00

0.00 0.00 0.00

_________________________________________________________________________________________________________

Nassau Freeport Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

7.5

170

BARBADOS Biotechnology (US $ mln): Barbados 1998 - 2008

Year

Barbados

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Barbados: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

974

0.03 0.03

100.00 100.00

0.00 0.00

0.00 0.00

_________________________________________________________________________________________________________

Bridgetown Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

7.6

BERMUDA Biotechnology (US $ mln): Bermuda 1998 - 2008

Year

Bermuda

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

171

Bermuda: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

1,467 1,583

0.01 0.01 0.01

60.00 40.00 100.00

0.00 0.00 0.00

0.00 0.00 0.00

_________________________________________________________________________________________________________

Hamilton Saint George Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

7.7

CANADA Biotechnology (US $ mln): Canada 1998 - 2008

Year

Canada

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

4 4 5 5 5 5 6 6 6 7 7

0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02%

0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

172

Canada: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

60 67 113 162 186 194 198 319 509 543 694 699 758 877 922

1.55 1.32 0.62 0.37 0.29 0.27 0.26 0.14 0.08 0.07 0.05 0.05 0.04 0.03 0.03 5.17

29.90 25.49 12.05 7.15 5.55 5.19 5.01 2.68 1.53 1.44 0.99 0.98 0.84 0.63 0.58 100.00

0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.02

0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.02

_________________________________________________________________________________________________________

Toronto Montreal Vancouver Ottawa Calgary Winnipeg Edmonton Hamilton Regina Quebec Halifax Thunder Bay Saint John's Niagara Falls Victoria Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

7.8

CAYMAN ISLANDS Biotechnology (US $ mln): Cayman Islands 1998 - 2008

Year

Cayman Islands

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

173

Cayman Islands: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

1,707 1,842 1,989 2,029

0.00 0.00 0.00 0.00 0.01

58.33 29.17 8.33 4.17 100.00

0.00 0.00 0.00 0.00 0.00

0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

George Town West Bay Savannah Bodden Town Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

7.9

CUBA Biotechnology (US $ mln): Cuba 1998 - 2008

Year

Cuba

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

174

Cuba: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

573 1,289 1,433 1,512 1,546 1,554 1,675 1,685 1,696 1,698 1,702

0.07 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.13

52.92 10.02 7.07 5.60 4.96 4.83 3.06 2.98 2.88 2.85 2.83 100.00

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Havana Santiago de Cuba Camagüey Holguin Guantanamo Santa Clara Bayamo Cienfuegos Pinar del Rio Las Tunas Matanzas Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

7.10 DOMINICA Biotechnology (US $ mln): Dominica 1998 - 2008 Year

Dominica

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

175

Dominica: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

1,893 2,047 2,048 2,049 2,050

0.00 0.00 0.00 0.00 0.00 0.00

64.71 8.82 8.82 8.82 8.82 100.00

0.00 0.00 0.00 0.00 0.00 0.00

0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Roseau Saint Joseph Portsmouth Marigot Berekua Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

7.11 DOMINICAN REPUBLIC Biotechnology (US $ mln): Dominican Republic 1998 - 2008 Year

Dominican Republic

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 1

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Dominican Republic: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

0.21 0.04 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.33

64.68 13.07 4.63 4.13 3.85 2.94 2.29 2.29 2.11 100.00

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Santo Domingo Santiago La Romana San Pedro de Macoris San Francisco de Macoris La Vega Barahona San Juan Puerto Plata Total

227 765 1,213 1,268 1,301 1,418 1,499 1,500 1,527

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

176

7.12 GREENLAND Biotechnology (US $ mln): Greenland 1998 - 2008 Year

Greenland

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Greenland: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

1,819 1,929 1,964 1,990 1,991 1,992 2,016 2,017 2,018 2,040 2,041 2,042 2,043 2,044 2,045

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01

28.57 11.90 9.52 7.14 7.14 7.14 4.76 4.76 4.76 2.38 2.38 2.38 2.38 2.38 2.38 100.00

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Nuuk Holsteinsborg Jakobshavn Julianehab Egedesminde Sukkertoppen Narsarsuaq Frederikshab Christianshab Uppernavik Thule Scoresbysund Godhavn Ammassalik Nanortalik Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

177

7.13 GRENADA Biotechnology (US $ mln): Grenada 1998 - 2008 Year

Grenada

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Grenada: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

1,811 1,986

0.00 0.00 0.00

80.00 20.00 100.00

0.00 0.00 0.00

0.00 0.00 0.00

_________________________________________________________________________________________________________

Saint George's Gouyave Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

7.14 GUADELOUPE Biotechnology (US $ mln): Guadeloupe 1998 - 2008 Year

Guadeloupe

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

178

Guadeloupe: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

1,515 1,749 1,789 1,822 1,833 1,844 1,850 1,860 1,861 1,903

0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.02

29.44 12.15 9.81 8.41 7.94 7.48 7.01 6.54 6.54 4.67 100.00

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Les Abymes Pointe-a-Pitre Le Gosier Moule Sainte Anne Morne-a-l'Eau Petit Bourg Sainte Rose Basse-Terre Saint-Claude Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

7.15 HAITI Biotechnology (US $ mln): Haiti 1998 - 2008 Year

Haiti

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

179

Haiti: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

642 1,456 1,637 1,644 1,645 1,767

0.06 0.01 0.00 0.00 0.00 0.00 0.08

70.39 10.12 5.51 5.36 5.36 3.27 100.00

0.00 0.00 0.00 0.00 0.00 0.00 0.00

0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Port-au-Prince Cap-Haitien Petionville Gonaives Les Cayes Port-de-Paix Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

7.16 JAMAICA Biotechnology (US $ mln): Jamaica 1998 - 2008 Year

Jamaica

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Jamaica: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

761 1,509 1,574 1,727 1,753 1,899

0.04 0.01 0.01 0.00 0.00 0.00 0.06

67.83 11.50 9.04 5.30 4.52 1.81 100.00

0.00 0.00 0.00 0.00 0.00 0.00 0.00

0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Kingston Spanish Town Montego Bay May Pen Mandeville Savanna-la-Mar Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

180

7.17 MARTINIQUE Biotechnology (US $ mln): Martinique 1998 - 2008 Year

Martinique

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Martinique: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

1,204 1,691 1,779 1,802 1,826 1,878 1,961 1,962

0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.03

53.66 13.17 8.78 7.80 6.83 4.88 2.44 2.44 100.00

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Fort-de-France Le Lamentin Sainte Marie Schoelcher Le François La Trinité Ducos Saint Pierre Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

181

7.18 NETHERLANDS ANTILLES Biotechnology (US $ mln): Netherlands Antilles 1998 - 2008 Year

Netherlands Antilles

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Netherlands Antilles: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

1,232 1,958 2,054

0.01 0.00 0.00 0.02

94.70 4.55 0.76 100.00

0.00 0.00 0.00 0.00

0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Willemstad Philipsburg Kralendijk Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

182

7.19 PUERTO RICO Biotechnology (US $ mln): Puerto Rico 1998 - 2008 Year

Puerto Rico

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Puerto Rico: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

635 887 984 988 1,096 1,241 1,260 1,261 1,297 1,399 1,442 1,523 1,573 1,595 1,648

0.06 0.03 0.03 0.03 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.26

22.99 12.29 10.07 9.99 7.43 5.56 5.35 5.34 4.91 3.96 3.46 2.69 2.23 2.03 1.72 100.00

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

San Juan Bayamon Ponce Carolina Caguas Guaynabo Mayaguez Arecibo Toa Baja Trujillo Alto Aguadilla Cayey Guayama Fajardo Catano Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

183

7.20 ST. KITTS AND NEVIS Biotechnology (US $ mln): St. Kitts and Nevis 1998 - 2008 Year

St. Kitts and Nevis

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

St. Kitts and Nevis: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

1,848 2,058

0.00 0.00 0.00

95.00 5.00 100.00

0.00 0.00 0.00

0.00 0.00 0.00

_________________________________________________________________________________________________________

Basseterre Charlestown Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

7.21 ST. LUCIA Biotechnology (US $ mln): St. Lucia 1998 - 2008 Year

St. Lucia

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

184

St. Lucia: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

1,687 1,938

0.00 0.00 0.00

82.81 17.19 100.00

0.00 0.00 0.00

0.00 0.00 0.00

_________________________________________________________________________________________________________

Castries Vieux Fort Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

7.22 ST. VINCENT AND THE GRENADINES Biotechnology (US $ mln): St. Vincent and the Grenadines 1998 - 2008 Year St. Vincent and the Grenadines

% of Region

% of Globe

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

St. Vincent and the Grenadines: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

1,823 2,055

0.00 0.00 0.00

95.00 5.00 100.00

0.00 0.00 0.00

0.00 0.00 0.00

_________________________________________________________________________________________________________

Kingstown Georgetown Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

185

7.23 TRINIDAD AND TOBAGO Biotechnology (US $ mln): Trinidad and Tobago 1998 - 2008 Year

Trinidad and Tobago

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Trinidad and Tobago: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

853 1,078 1,156 1,714

0.03 0.02 0.02 0.00 0.08

45.67 26.77 22.83 4.72 100.00

0.00 0.00 0.00 0.00 0.00

0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Port-of-Spain San Fernando Arima Scarborough Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

186

7.24 UNITED STATES Biotechnology (US $ mln): United States 1998 - 2008 Year

United States

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

17,686 19,455 21,400 23,540 25,894 28,484 31,332 34,465 37,912 41,703 45,873

99.97% 99.97% 99.97% 99.98% 99.98% 99.98% 99.98% 99.98% 99.98% 99.98% 99.98%

99.01% 99.07% 99.12% 99.17% 99.22% 99.24% 99.26% 99.27% 99.29% 99.31% 99.32%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

United States: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

6,479.54 2,345.60 2,156.08 1,255.01 1,112.52 794.67 785.54 773.33 752.46 721.24 716.93 600.05 511.72 477.72 465.36 8,535.81 28483.60

22.75 8.23 7.57 4.41 3.91 2.79 2.76 2.71 2.64 2.53 2.52 2.11 1.80 1.68 1.63 29.97 100.00

22.74 8.23 7.57 4.41 3.90 2.79 2.76 2.71 2.64 2.53 2.52 2.11 1.80 1.68 1.63 29.96 99.98

22.58 8.17 7.51 4.37 3.88 2.77 2.74 2.69 2.62 2.51 2.50 2.09 1.78 1.66 1.62 29.74 99.24

_________________________________________________________________________________________________________

New York Los Angeles Chicago Houston Philadelphia Dallas San Jose San Francisco San Diego Detroit Phoenix San Antonio Indianapolis Baltimore Washington D.C. Others Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

187

7.25 VIRGIN ISLANDS, US Biotechnology (US $ mln): Virgin Islands, US 1998 - 2008 Year

Virgin Islands, US

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Virgin Islands, US: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

1,531 1,874 1,875 1,908 1,956 2,014

0.01 0.00 0.00 0.00 0.00 0.00 0.01

57.58 12.12 12.12 9.09 6.06 3.03 100.00

0.00 0.00 0.00 0.00 0.00 0.00 0.00

0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Charlotte Amalie Road Town Frederiksted Christiansted Cruz Bay Spanish Town Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

188

8 OCEANA: BIOTECHNOLOGY 8.1

EXECUTIVE SUMMARY Market Potential for Biotechnology in Oceana (US $ mln): 2003

Country

Latent Demand US $ mln

% of Oceana

_________________________________________________________________________________________________________

Australia New Zealand Fiji Guam New Caledonia French Polynesia Solomon Islands Northern Mariana Island Western Samoa American Samoa Micronesia Federation Vanuatu Tonga Palau Marshall Islands Cook Island Kiribati Nauru Norfolk Island Pacific Islands Trust Christmas Island Wallis and Futuna Tuvalu Niue Tokelau Other Total

3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4

83.88% 12.65% 1.04% 0.59% 0.56% 0.48% 0.17% 0.17% 0.11% 0.09% 0.05% 0.04% 0.04% 0.02% 0.02% 0.02% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.00% 0.00% 0.00% 0.00% 100.00%

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

189

Market Potential for Biotechnology in Oceana (US $ mln): 2003

New Zealand Fiji Guam Other Australia

The Market for Biotechnology in Oceana: 1998 - 2008 Year

US $ mln

% of Globe

3.01 3.09 3.16 3.24 3.33 3.56 3.81 4.08 4.38 4.69 5.03

0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01

_________________________________________________________________________________________________________

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

8.2

190

AMERICAN SAMOA Biotechnology (US $ mln): American Samoa 1998 - 2008

Year

American Samoa

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.09% 0.09% 0.09% 0.09% 0.09% 0.09% 0.09% 0.09% 0.09% 0.08% 0.08%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

American Samoa: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

1,907 1,953 1,954 2,011 2,012

0.00 0.00 0.00 0.00 0.00 0.00

33.33 22.22 22.22 11.11 11.11 100.00

0.03 0.02 0.02 0.01 0.01 0.09

0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Pago Pago Leone Fagatogo Utulei Vaitogi Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

8.3

191

AUSTRALIA Biotechnology (US $ mln): Australia 1998 - 2008

Year

Australia

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

3 3 3 3 3 3 3 3 4 4 4

84.32% 84.18% 84.04% 83.89% 83.78% 83.88% 84.02% 84.15% 84.28% 84.40% 84.52%

0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Australia: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

85 87 125 190 314 441 747 750 900 1,048 1,086 1,173 1,237

0.87 0.86 0.54 0.27 0.14 0.09 0.04 0.04 0.03 0.02 0.02 0.02 0.01 2.98

29.32 28.92 18.26 9.21 4.70 3.15 1.49 1.49 1.03 0.73 0.66 0.55 0.49 100.00

24.59 24.26 15.32 7.73 3.94 2.64 1.25 1.25 0.87 0.61 0.55 0.46 0.41 83.88

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01

_________________________________________________________________________________________________________

Sydney Melbourne Brisbane Perth Adelaide Canberra Newcastle Gold Coast Hobart Wollongong Townsville Darwin Geelong Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

8.4

192

FIJI Biotechnology (US $ mln): Fiji 1998 - 2008

Year

Fiji

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.85% 0.91% 0.97% 1.04% 1.09% 1.04% 0.98% 0.93% 0.87% 0.82% 0.78%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Fiji: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

Suva Nadi

863 1,724

0.03 0.00 0.04

90.91 9.09 100.00

0.95 0.09 1.04

0.00 0.00 0.00

_________________________________________________________________________________________________________

Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

8.5

FRENCH POLYNESIA Biotechnology (US $ mln): French Polynesia 1998 - 2008

Year

French Polynesia

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.47% 0.47% 0.48% 0.48% 0.49% 0.48% 0.48% 0.48% 0.47% 0.47% 0.46%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

193

French Polynesia: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

1,438 1,693 1,801 1,904 1,947 2,008

0.01 0.00 0.00 0.00 0.00 0.00 0.02

52.17 21.74 13.04 6.52 4.35 2.17 100.00

0.25 0.11 0.06 0.03 0.02 0.01 0.48

0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Papeete Mahina Papara Mataiea Afareaitu Teahupoo Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

8.6

GUAM Biotechnology (US $ mln): Guam 1998 - 2008

Year

Guam

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.55% 0.56% 0.57% 0.59% 0.60% 0.59% 0.58% 0.57% 0.55% 0.54% 0.53%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Guam: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

1,385 1,587 1,682 1,945 2,007

0.01 0.01 0.00 0.00 0.00 0.02

49.80 26.17 18.61 3.63 1.79 100.00

0.29 0.15 0.11 0.02 0.01 0.59

0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Dededo Tamuning Santa Rita Talofofo Agana Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

8.7

194

KIRIBATI Biotechnology (US $ mln): Kiribati 1998 - 2008

Year

Kiribati

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Kiribati: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

1,994

0.00 0.00

100.00 100.00

0.01 0.01

0.00 0.00

_________________________________________________________________________________________________________

Tarawa Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

8.8

NAURU Biotechnology (US $ mln): Nauru 1998 - 2008

Year

Nauru

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

195

Nauru: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

2,002

0.00 0.00

100.00 100.00

0.01 0.01

0.00 0.00

_________________________________________________________________________________________________________

Yaren Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

8.9

NEW CALEDONIA Biotechnology (US $ mln): New Caledonia 1998 - 2008

Year

New Caledonia

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.55% 0.56% 0.56% 0.56% 0.56% 0.56% 0.56% 0.56% 0.55% 0.55% 0.55%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

New Caledonia: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

1,209 1,882 1,924 1,925 1,963 1,997 2,031

0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.02

76.74 6.98 4.65 4.65 3.49 2.33 1.16 100.00

0.43 0.04 0.03 0.03 0.02 0.01 0.01 0.56

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Noumea Dumbea Canala Bourail Thio Hienghene Houailu Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

196

8.10 NEW ZEALAND Biotechnology (US $ mln): New Zealand 1998 - 2008 Year

New Zealand

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 1 1 1 1

12.50% 12.55% 12.60% 12.65% 12.69% 12.65% 12.61% 12.56% 12.52% 12.47% 12.43%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

New Zealand: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

263 652 657 963 1,091 1,099 1,145 1,246 1,296 1,430 1,448 1,455 1,460 1,496 1,517

0.17 0.06 0.06 0.03 0.02 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.45

38.01 12.80 12.46 6.06 4.32 4.25 3.87 3.15 2.83 2.03 1.94 1.89 1.87 1.69 1.57 1.25 100.00

4.81 1.62 1.58 0.77 0.55 0.54 0.49 0.40 0.36 0.26 0.25 0.24 0.24 0.21 0.20 0.16 12.65

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Auckland Wellington Christchurch Hamilton Napier-Hastings Dunedin Waitemata Tauranga Palmerston North Rotorua Nelson Invercargill New Plymouth Whangarei Wanganui Others Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

197

8.11 NORTHERN MARIANA ISLAND Biotechnology (US $ mln): Northern Mariana Island 1998 - 2008 Year

Northern Mariana Island

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.15% 0.16% 0.16% 0.17% 0.17% 0.17% 0.16% 0.16% 0.16% 0.15% 0.15%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Northern Mariana Island: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

1,569

0.01 0.01

100.00 100.00

0.17 0.17

0.00 0.00

_________________________________________________________________________________________________________

Saipan Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

8.12 SOLOMON ISLANDS Biotechnology (US $ mln): Solomon Islands 1998 - 2008 Year

Solomon Islands

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.16% 0.16% 0.16% 0.17% 0.17% 0.17% 0.16% 0.16% 0.16% 0.16% 0.15%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

198

Solomon Islands: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

1,568

0.01 0.01

100.00 100.00

0.17 0.17

0.00 0.00

_________________________________________________________________________________________________________

Honiara Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

8.13 TONGA Biotechnology (US $ mln): Tonga 1998 - 2008 Year

Tonga

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Tonga: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

1,868

0.00 0.00

100.00 100.00

0.04 0.04

0.00 0.00

_________________________________________________________________________________________________________

Nuku'alofa Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

199

8.14 TUVALU Biotechnology (US $ mln): Tuvalu 1998 - 2008 Year

Tuvalu

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Tuvalu: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

2,060

0.00 0.00

100.00 100.00

0.00 0.00

0.00 0.00

_________________________________________________________________________________________________________

Funafuti Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

8.15 VANUATU Biotechnology (US $ mln): Vanuatu 1998 - 2008 Year

Vanuatu

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.04% 0.04% 0.04% 0.04% 0.05% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

200

Vanuatu: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

1,862

0.00 0.00

100.00 100.00

0.04 0.04

0.00 0.00

_________________________________________________________________________________________________________

Port Vila Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

8.16 WESTERN SAMOA Biotechnology (US $ mln): Western Samoa 1998 - 2008 Year

Western Samoa

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.11% 0.11% 0.11% 0.11% 0.11% 0.11% 0.11% 0.11% 0.11% 0.11% 0.11%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Western Samoa: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

Apia

1,684

0.00 0.00

100.00 100.00

0.11 0.11

0.00 0.00

_________________________________________________________________________________________________________

Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

201

9 THE MIDDLE EAST: BIOTECHNOLOGY 9.1

EXECUTIVE SUMMARY Market Potential for Biotechnology in the Middle East (US $ mln): 2003

Country

Latent Demand US $ mln

% of the Middle East

3 2 2 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12

25.94% 16.38% 13.43% 11.89% 6.43% 3.47% 3.44% 3.12% 2.94% 1.71% 1.41% 1.20% 1.19% 1.14% 1.04% 0.99% 0.87% 0.84% 0.74% 0.59% 0.58% 0.42% 0.17% 0.06% 100.00%

_________________________________________________________________________________________________________

Turkey Pakistan Saudi Arabia Iran Israel Iraq Uzbekistan United Arab Emirates Syrian Arab Republic Kuwait Azerbaijan Turkmenistan Afghanistan Oman Lebanon Jordan Qatar Yemen Kyrgyzstan Bahrain Armenia Tajikistan West Bank Gaza Strip Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

202

Market Potential for Biotechnology in the Middle East (US $ mln): 2003 Saudi Arabia

Iran

Pakistan

Other Turkey

The Market for Biotechnology in the Middle East: 1998 - 2008 Year

US $ mln

% of Globe

9.89 10.09 10.29 10.49 10.78 11.52 12.39 13.34 14.35 15.45 16.63

0.06 0.05 0.05 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04

_________________________________________________________________________________________________________

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

9.2

203

AFGHANISTAN Biotechnology (US $ mln): Afghanistan 1998 - 2008

Year

Afghanistan

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

1.10% 1.13% 1.16% 1.19% 1.21% 1.19% 1.16% 1.14% 1.11% 1.08% 1.05%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Afghanistan: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

460 1,255 1,358 1,476 1,711 1,715 1,775 1,782 1,821 1,824

0.09 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.14

64.17 10.18 7.98 5.90 2.61 2.57 1.85 1.80 1.49 1.44 100.00

0.77 0.12 0.10 0.07 0.03 0.03 0.02 0.02 0.02 0.02 1.19

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Kabul Qandahar Herat Mazar-e-Sharif Jalalabad Qonduz Baghlan Meymaneh Pol-e-Khomri Ghazni Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

9.3

204

ARMENIA Biotechnology (US $ mln): Armenia 1998 - 2008

Year

Armenia

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.58% 0.58% 0.58% 0.58% 0.58% 0.58% 0.58% 0.58% 0.58% 0.58% 0.58%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Armenia: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

818 1,551 1,600 1,830 1,840 1,843 1,872 1,886 1,905 1,913 1,915 1,936 1,937 1,940 1,941

0.04 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.07

56.57 9.39 7.74 2.89 2.75 2.70 2.15 2.02 1.65 1.51 1.47 1.24 1.24 1.15 1.15 4.40 100.00

0.33 0.05 0.05 0.02 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.03 0.58

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Yerevan Gyumri Kirovakan Hrazdan Echmiadzin Abovian Kaphan Hoktemberian Charentsavan Artashat Kamo Sevan Goris Massis Ashtarak Others Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

9.4

205

AZERBAIJAN Biotechnology (US $ mln): Azerbaijan 1998 - 2008

Year

Azerbaijan

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

1.55% 1.50% 1.46% 1.41% 1.38% 1.41% 1.45% 1.49% 1.53% 1.58% 1.62%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Azerbaijan: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

393 1,128 1,229 1,643 1,722 1,733 1,768 1,803 1,895

0.11 0.02 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.16

69.28 10.96 9.11 2.76 2.09 2.01 1.66 1.38 0.75 100.00

0.98 0.15 0.13 0.04 0.03 0.03 0.02 0.02 0.01 1.41

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Baku Gyandzha Sumgait Mingechaur Sheki Nakhichevan Lenkoran Stepanakert Shemakha Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

9.5

206

BAHRAIN Biotechnology (US $ mln): Bahrain 1998 - 2008

Year

Bahrain

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.59% 0.59% 0.59% 0.59% 0.59% 0.59% 0.59% 0.59% 0.59% 0.58% 0.58%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Bahrain: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

864 1,153 1,375 1,635 1,864

0.03 0.02 0.01 0.00 0.00 0.07

49.67 25.49 15.69 6.86 2.29 100.00

0.29 0.15 0.09 0.04 0.01 0.59

0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Manama Muharraq Jidd Hafs Isa Town Al Hidd Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

9.6

207

IRAN Biotechnology (US $ mln): Iran 1998 - 2008

Year

Iran

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

1 1 1 1 1 1 1 2 2 2 2

11.49% 11.62% 11.75% 11.88% 11.98% 11.89% 11.77% 11.65% 11.53% 11.41% 11.29%

0.01% 0.01% 0.01% 0.01% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Iran: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

117 313 433 438 483 654 667 685 695 932 940 945 999 1,039 1,088

0.59 0.14 0.10 0.09 0.08 0.06 0.05 0.05 0.05 0.03 0.03 0.03 0.02 0.02 0.02 1.37

42.86 10.38 7.00 6.89 6.01 4.11 3.98 3.85 3.74 2.13 2.09 2.06 1.82 1.63 1.43 100.00

5.10 1.23 0.83 0.82 0.72 0.49 0.47 0.46 0.44 0.25 0.25 0.25 0.22 0.19 0.17 11.89

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Tehran Mashad Isfahan Tabriz Shiraz Ahvaz Bakhtaran Qom Karaj Orumiyeh Abadan Rasht Kerman Yazd Bandar 'Abbas Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

9.7

208

IRAQ Biotechnology (US $ mln): Iraq 1998 - 2008

Year

Iraq

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 1 1 1 1

4.03% 3.84% 3.66% 3.48% 3.36% 3.47% 3.63% 3.80% 3.97% 4.15% 4.33%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Iraq: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

213 916 956 980 1,180 1,267 1,330 1,380 1,436 1,533 1,538 1,545 1,582 1,746

0.23 0.03 0.03 0.03 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.40

56.60 7.51 6.95 6.51 4.07 3.40 2.96 2.62 2.25 1.69 1.67 1.61 1.40 0.75 100.00

1.97 0.26 0.24 0.23 0.14 0.12 0.10 0.09 0.08 0.06 0.06 0.06 0.05 0.03 3.47

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Baghdad Basra Mosul Kirkuk Irbil As-Sulaymaniyah An-Najaf Al-Hillah Karbala An-Nasiriyah Ar-Ramadi Al-Amarah Ba'qubah Samarra Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

9.8

209

ISRAEL Biotechnology (US $ mln): Israel 1998 - 2008

Year

Israel

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

1 1 1 1 1 1 1 1 1 1 1

6.50% 6.48% 6.46% 6.44% 6.42% 6.43% 6.46% 6.48% 6.50% 6.52% 6.53%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Israel: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

225 300 415 598 625 680 686 714

0.21 0.15 0.10 0.06 0.06 0.05 0.05 0.05 0.74

28.97 19.77 13.77 8.65 8.09 7.16 7.10 6.49 100.00

1.86 1.27 0.89 0.56 0.52 0.46 0.46 0.42 6.43

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Jerusalem Tel Aviv Haifa Holon Petach-Tikva Ramat Gan Beersheba Bene Beraq Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

9.9

210

JORDAN Biotechnology (US $ mln): Jordan 1998 - 2008

Year

Jordan

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.94% 0.96% 0.97% 0.99% 1.00% 0.99% 0.98% 0.96% 0.95% 0.93% 0.92%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Jordan: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

602 1,047 1,341 1,423 1,729 1,794 1,839

0.06 0.02 0.01 0.01 0.00 0.00 0.00 0.11

55.97 19.09 10.07 8.33 2.92 1.99 1.62 100.00

0.56 0.19 0.10 0.08 0.03 0.02 0.02 0.99

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Amman Zarqa Irbid Salt Ajlun Jarash Madaba Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

211

9.10 KUWAIT Biotechnology (US $ mln): Kuwait 1998 - 2008 Year

Kuwait

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

1.73% 1.73% 1.72% 1.71% 1.71% 1.71% 1.72% 1.72% 1.73% 1.74% 1.74%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Kuwait: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

579 608 712 1,098

0.07 0.06 0.05 0.02 0.20

33.77 32.01 24.50 9.71 100.00

0.58 0.55 0.42 0.17 1.71

0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Salmiya Hawalli Jahra Kuwait Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

212

9.11 KYRGYZSTAN Biotechnology (US $ mln): Kyrgyzstan 1998 - 2008 Year

Kyrgyzstan

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.74% 0.74% 0.74% 0.74% 0.73% 0.74% 0.74% 0.74% 0.74% 0.74% 0.74%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Kyrgyzstan: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

687 1,131 1,616 1,634 1,769 1,807

0.05 0.02 0.00 0.00 0.00 0.00 0.08

62.08 20.92 5.80 5.50 3.14 2.55 100.00

0.46 0.15 0.04 0.04 0.02 0.02 0.74

0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Bishkek Osh Dzhalal-Abad Przhevalsk Kyzyl-Kiya Naryn Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

213

9.12 LEBANON Biotechnology (US $ mln): Lebanon 1998 - 2008 Year

Lebanon

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.97% 0.99% 1.01% 1.04% 1.05% 1.04% 1.02% 1.00% 0.98% 0.96% 0.94%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Lebanon: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

518 986 1,388 1,603 1,955

0.08 0.03 0.01 0.01 0.00 0.12

64.82 21.61 8.64 4.32 0.61 100.00

0.67 0.22 0.09 0.04 0.01 1.04

0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Beirut Tripoli Zahle Sidon Tyre Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

214

9.13 OMAN Biotechnology (US $ mln): Oman 1998 - 2008 Year

Oman

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

1.13% 1.13% 1.13% 1.14% 1.14% 1.14% 1.13% 1.13% 1.13% 1.12% 1.12%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Oman: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

539 991 1,218 1,219

0.08 0.03 0.02 0.02 0.13

57.47 19.54 11.49 11.49 100.00

0.65 0.22 0.13 0.13 1.14

0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Muscat Matrah Nizwa Salala Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

215

9.14 PAKISTAN Biotechnology (US $ mln): Pakistan 1998 - 2008 Year

Pakistan

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

2 2 2 2 2 2 2 2 2 3 3

16.28% 16.31% 16.35% 16.38% 16.40% 16.38% 16.35% 16.32% 16.29% 16.25% 16.21%

0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Pakistan: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

104 149 290 395 409 416 446 512 774 792 944

0.72 0.41 0.15 0.11 0.10 0.10 0.09 0.08 0.04 0.04 0.03 1.89

38.40 21.77 8.14 5.86 5.54 5.38 4.86 4.17 2.23 2.15 1.50 100.00

6.29 3.57 1.33 0.96 0.91 0.88 0.80 0.68 0.36 0.35 0.25 16.38

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01

_________________________________________________________________________________________________________

Karachi Lahore Faisalabad Rawalpindi Hyderabad Multan Gujranwala Peshawar Sialkot Sargodha Islamabad Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

216

9.15 QATAR Biotechnology (US $ mln): Qatar 1998 - 2008 Year

Qatar

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.86% 0.86% 0.87% 0.87% 0.88% 0.87% 0.87% 0.86% 0.86% 0.85% 0.85%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Qatar: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

419

0.10 0.10

100.00 100.00

0.87 0.87

0.00 0.00

_________________________________________________________________________________________________________

Doha Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

9.16 SAUDI ARABIA Biotechnology (US $ mln): Saudi Arabia 1998 - 2008 Year

Saudi Arabia

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

1 1 1 1 1 2 2 2 2 2 2

13.17% 13.26% 13.34% 13.42% 13.48% 13.43% 13.35% 13.28% 13.20% 13.12% 13.04%

0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

217

Saudi Arabia: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

118 199 228 381 394 525 805 810 934 967 1,062 1,095 1,298 1,339

0.58 0.26 0.21 0.12 0.11 0.08 0.04 0.04 0.03 0.03 0.02 0.02 0.01 0.01 1.55

37.31 16.59 13.68 7.46 7.21 4.98 2.51 2.49 1.87 1.74 1.34 1.24 0.82 0.75 100.00

5.01 2.23 1.84 1.00 0.97 0.67 0.34 0.33 0.25 0.23 0.18 0.17 0.11 0.10 13.43

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01

_________________________________________________________________________________________________________

Jiddah Riyadh Mecca Taif Medina Dammam Hufuf Haradh Tabuk Buraydah Al-Mubarraz Khamis-Mushait Jizan Abha Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

9.17 SYRIAN ARAB REPUBLIC Biotechnology (US $ mln): Syrian Arab Republic 1998 - 2008 Year

Syrian Arab Republic

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

2.86% 2.89% 2.91% 2.94% 2.96% 2.94% 2.92% 2.89% 2.87% 2.85% 2.82%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

218

Syrian Arab Republic: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

386 404 813 1,051 1,101 1,471 1,489 1,541 1,631 1,636 1,647

0.12 0.11 0.04 0.02 0.02 0.01 0.01 0.01 0.00 0.00 0.00 0.34

33.99 31.99 11.34 6.34 5.63 2.42 2.29 1.92 1.39 1.37 1.32 100.00

1.00 0.94 0.33 0.19 0.17 0.07 0.07 0.06 0.04 0.04 0.04 2.94

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Damascus Aleppo Homs Latakia Hama Dayr az-Zawr Raqqa Hasakeh Tartus Idlib Dar'a Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

9.18 TAJIKISTAN Biotechnology (US $ mln): Tajikistan 1998 - 2008 Year

Tajikistan

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.42% 0.42% 0.42% 0.42% 0.42% 0.42% 0.42% 0.42% 0.42% 0.42% 0.42%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

219

Tajikistan: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

895 1,465 1,735 1,752 1,871 1,906 1,951

0.03 0.01 0.00 0.00 0.00 0.00 0.00 0.05

63.64 17.11 6.63 5.88 2.99 2.25 1.50 100.00

0.27 0.07 0.03 0.02 0.01 0.01 0.01 0.42

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Dushanbe Khodzhent Kulyab Kurgan-Tyube Kanibadam Tursunzade Khorog Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

9.19 TURKEY Biotechnology (US $ mln): Turkey 1998 - 2008 Year

Turkey

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

3 3 3 3 3 3 3 3 4 4 4

26.26% 26.16% 26.06% 25.95% 25.86% 25.94% 26.04% 26.14% 26.23% 26.32% 26.40%

0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

220

Turkey: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

73 165 168 258 277 316 323 363 554 575 631 643 646 720 786

1.15 0.36 0.34 0.18 0.16 0.14 0.14 0.12 0.07 0.07 0.06 0.06 0.06 0.05 0.04 2.99

38.42 12.01 11.51 5.94 5.30 4.65 4.54 4.07 2.42 2.28 1.99 1.97 1.95 1.57 1.37 100.00

9.97 3.11 2.99 1.54 1.38 1.21 1.18 1.05 0.63 0.59 0.52 0.51 0.51 0.41 0.36 25.94

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01

_________________________________________________________________________________________________________

Istanbul Izmir Ankara Bursa Adana Mersin (Icel) Antalya Konya Samsun Gaziantep Kayseri Diyarbakir Eskisehir Sanli-Urfa Malatya Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

9.20 TURKMENISTAN Biotechnology (US $ mln): Turkmenistan 1998 - 2008 Year

Turkmenistan

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

1.41% 1.34% 1.27% 1.20% 1.16% 1.20% 1.26% 1.32% 1.39% 1.46% 1.53%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

221

Turkmenistan: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

533 904 1,053 1,381

0.08 0.03 0.02 0.01 0.14

54.82 22.18 15.43 7.58 100.00

0.66 0.27 0.19 0.09 1.20

0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Ashgabat Chardzhou Tashauz Krasnovodsk Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

9.21 UNITED ARAB EMIRATES Biotechnology (US $ mln): United Arab Emirates 1998 - 2008 Year

United Arab Emirates

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 1

3.07% 3.09% 3.11% 3.12% 3.14% 3.12% 3.11% 3.09% 3.07% 3.05% 3.04%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

United Arab Emirates: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

349 373 624 661

0.13 0.12 0.06 0.06 0.36

35.47 32.40 16.67 15.47 100.00

1.11 1.01 0.52 0.48 3.12

0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Dubai Abu Dhabi Sharjah Ras al-Khaimah Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

222

9.22 UZBEKISTAN Biotechnology (US $ mln): Uzbekistan 1998 - 2008 Year

Uzbekistan

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 1 1

3.28% 3.33% 3.38% 3.44% 3.48% 3.44% 3.39% 3.34% 3.29% 3.25% 3.20%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Uzbekistan: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

271 746 1,014 1,029 1,133 1,195 1,243 1,277 1,311 1,312 1,393 1,404 1,410 1,440 1,459

0.16 0.04 0.02 0.02 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.40

41.18 11.24 6.12 5.82 4.45 3.97 3.62 3.36 3.10 3.10 2.60 2.54 2.48 2.26 2.13 2.03 100.00

1.42 0.39 0.21 0.20 0.15 0.14 0.12 0.12 0.11 0.11 0.09 0.09 0.09 0.08 0.07 0.07 3.44

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Tashkent Samarkand Namangan Andizhan Bukhara Fergana Kokand Nukus Chirchik Karshi Angren Urgench Margilan Almalyk Navoi Others Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

223

9.23 YEMEN Biotechnology (US $ mln): Yemen 1998 - 2008 Year

Yemen

% of Region

% of Globe

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0 0 0 0 0 0 0 0 0 0 0

0.85% 0.85% 0.85% 0.84% 0.84% 0.84% 0.84% 0.85% 0.85% 0.85% 0.86%

0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

_________________________________________________________________________________________________________

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

Yemen: Biotechnology in 2003, US $ mln City

World Rank

US $ mln

%Country

%Region

%World

878 1,016 1,271 1,333 1,334 1,795 1,965 1,975

0.03 0.02 0.01 0.01 0.01 0.00 0.00 0.00 0.10

33.39 24.86 13.92 12.12 12.04 2.35 0.70 0.63 100.00

0.28 0.21 0.12 0.10 0.10 0.02 0.01 0.01 0.84

0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

_________________________________________________________________________________________________________

Sanaa Aden Taizz Hodeida Mukalla Dhamar El Beida Hajja Total

_________________________________________________________________________________________________________

Source: Philip M. Parker, INSEAD, copyright 2003, www.icongrouponline.com

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

224

10 DISCLAIMERS, WARRANTEES, AND USER AGREEMENT PROVISIONS 10.1 DISCLAIMERS & SAFE HARBOR Summary disclaimer. This publication ("Report") does not constitute legal, valuation, tax, or financial consulting advice. Nor is it a statement on the performance, management capability or future potential (good or bad) of the company(ies), industry(ies), product(s), region(s), city(ies) or country(ies) discussed. It is offered as an information service to clients, associates, and academicians. Those interested in specific guidance for legal, strategic, and/or financial or accounting matters should seek competent professional assistance from their own advisors. Information was furnished to ICON Group Ltd. ("ICON Group"), and its subsidiaries (ICON Group International, Inc.), by its internal researchers and/or extracted from public filings, or sources available within the public domain, including other information providers (e.g. EDGAR filings, national organizations and international organizations). ICON Group does not promise or warrant that we will obtain information from any particular independent source. Published regularly by ICON Group, this and similar reports provide analysis on cities, countries, industries, and/or foreign and domestic companies which may or may not be publicly traded. ICON Group reports are used by various companies and persons including consulting firms, investment officers, pension fund managers, registered representatives, and other financial service professionals. Any commentary, observations or discussion by ICON Group about a country, city, region, industry or company does not constitute a recommendation to buy or sell company shares or make investment decisions. Further, the financial condition or outlook for each industry, city, country, or company may change after the date of the publication, and ICON Group does not warrant, promise or represent that it will provide report users with notice of that change, nor will ICON Group promise updates on the information presented. Safe Harbor for Forward-Looking Statements. ICON Group reports, including the present report, make numerous forward-looking statements which should be treated as such. Forwardlooking statements are made pursuant to the safe harbor provisions of the Private Securities Reform Act of 1995, and similar local laws. Forward-looking statements involve known and unknown risks and uncertainties, which may cause a company's, city's, country's or industry's actual results or outlook in future periods to differ materially from those forecasted. These risks and uncertainties include, among other things, product price volatility, exchange rate volatility, regulation volatility, product demand volatility, data inaccuracies, computer- or softwaregenerated calculation inaccuracies, market competition, changes in management style, changes in corporate strategy, and risks inherent in international and corporate operations. Forward-looking statements can be identified in statements by the fact that they do not relate strictly to historical or

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

225

current facts. They use words such as "anticipate,'' "estimate," "expect,'' "project,'' "intend,'' "plan,'' "feel", "think", "hear," "guess," "forecast," "believe," and other words and terms of similar meaning in connection with any discussion of future operating, economic or financial performance. This equally applies to all statements relating to an industry, city, country, region, economic variable or company financial situation. ICON Group recommends that the reader follow the advice of Nancy M. Smith, Director of SEC's Office of Investor Education and Assistance, who has been quoted to say, "Never, ever, make an investment based solely on what you read in an online newsletter or Internet bulletin board, especially if the investment involves a small, thinly-traded company that isn't well known … Assume that the information about these companies is not trustworthy unless you can prove otherwise through your own independent research." Similar recommendations apply to decisions relating to industry studies, product category studies, corporate strategies discussions and country evaluations. In the case of ICON Group reports, many factors can affect the actual outcome of the period discussed, including exchange rate volatility, changes in accounting standards, the lack of oversight or comparability in accounting standards, changes in economic conditions, changes in competition, changes in the global economy, changes in source data quality, changes in reported data quality, changes in methodology and similar factors. Information Accuracy. Although the statements in this report are derived from or based upon various information sources and/or econometric models that ICON Group believes to be reliable, we do not guarantee their accuracy, reliability, quality, and any such information, or resulting analyses, may be incomplete, rounded, inaccurate or condensed. All estimates included in this report are subject to change without notice. This report is for informational purposes only and is not intended as a recommendation to invest in a city, country, industry or product area, or an offer or solicitation with respect to the purchase or sale of a security, stock, or financial instrument. This report does not take into account the investment objectives, financial situation or particular needs of any particular person or legal entity. With respect to any specific company, city, country, region, or industry that might be discussed in this report, investors should obtain individual financial advice based on their own particular circumstances before making an investment decision on the basis of the information in this report. Investing in either U.S. or nonU.S. securities or markets entails inherent risks. In addition, exchange rate movements may have an effect on the reliability of the estimates provided in this report. ICON Group is not a registered Investment Adviser or a Broker/Dealer.

10.2 ICON GROUP LTD. USER AGREEMENT PROVISIONS Ownership. User agrees that ICON Group Ltd. ("ICON Group") and its subsidiaries (ICON Group International, Inc.) retains all rights, title and interests, including copyright and other proprietary rights, in this report and all material, including but not limited to text, images, and other multimedia data, provided or made available as part of this report ("Report").

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

226

Restrictions on Use. User agrees that it will not copy nor license, sell, transfer, make available or otherwise distribute the Report to any entity or person, except that User may (a) make available to its employees electronic copies of Report, (b) allow its employees to store, manipulate, and reformat Report, and (c) allow its employees to make paper copies of Report, provided that such electronic and paper copies are used solely internally and are not distributed to any third parties. In all cases the User agrees to fully inform and distribute to other internal users all discussions covering the methodology of this Report and the disclaimers and caveats associated with this Report. User shall use its best efforts to stop any unauthorized copying or distribution immediately after such unauthorized use becomes known. The provisions of this paragraph are for the benefit of ICON Group and its information resellers, each of which shall have the right to enforce its rights hereunder directly and on its own behalf. No Warranty. The Report is provided on an "AS IS" basis. ICON GROUP DISCLAIMS ANY AND ALL WARRANTIES, INCLUDING BUT NOT LIMITED TO THE IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE, RELATING TO THIS AGREEMENT, PERFORMANCE UNDER THIS AGREEMENT, THE REPORT. ICON Group makes no warranties regarding the completeness, accuracy or availability of the Report. Limitation of Liability. In no event shall ICON Group, its employees or its agent, resellers and distributors be liable to User or any other person or entity for any direct, indirect, special, exemplary, punitive, or consequential damages, including lost profits, based on breach of warranty, contract, negligence, strict liability or otherwise, arising from the use of the report or under this Agreement or any performance under this Agreement, whether or not they or it had any knowledge, actual or constructive, that such damages might be incurred. Indemnification. User shall indemnify and hold harmless ICON Group and its resellers, distributors and information providers against any claim, damages, loss, liability or expense arising out of User's use of the Report in any way contrary to this Agreement. © ICON Group Ltd., 2003. All rights reserved. Any unauthorized use, duplication or disclosure is prohibited by law and will result in prosecution. Text, graphics, and HTML or other computer code are protected by US and International Copyright Laws, and may not be copied, reprinted, published, translated, hosted, or otherwise distributed by any means without explicit permission. Permission is granted to quote small portions of this report with proper attribution. Media quotations with source attributions are encouraged. Reporters requesting additional information or editorial comments should contact ICON Group via email at [email protected]. Sources: This report was prepared from a variety of sources including excerpts from documents and official reports or databases published by the World Bank, the U.S. Department of Commerce, the U.S. State Department, various national agencies, the International Monetary Fund, the Central Intelligence Agency, the United Nations, and ICON Group Ltd.

www.icongrouponline.com

Ó2003 ICON Group Ltd.

Biotechnology

227

END

www.icongrouponline.com

Ó2003 ICON Group Ltd.